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Durante il Dottorato di ricerca mi sono occupato dello studio della regolazione 
dell´espressione genica in Neisseria meningitidis. In particolare ho studiato la 
regolazione trascrizionale in seguito a stess ossidativo, ho caratterizzato un circuito di 
regolazione che coinvolge un piccolo RNA non codificante (sRNA) e lo chaperone Hfq, 
e piú in dettaglio ho approfondito la complessa regolazione trascrizionale di NadA, 
argomento quest’ultimo del lavoro di tesi di seguito presentato. 
Nel periodo del Dottorato di Ricerca sono stato co-autore dei seguenti lavori 
scientifici: 
 
Ieva R, Roncarati D, Metruccio MM, Seib KL, Scarlato V, Delany I. “OxyR tightly 
regulates catalase expression in Neisseria meningitidis through both repressive and 
activation mechanisms.” Mol Microbiol. 2008 Dec;70(5):1152-65. 
 
Metruccio MM, Fantappiè L, Serruto D, Muzzi A, Roncarati D, Donati C, Scarlato V, 
Delany I. “The Hfq-dependent small noncoding RNA NrrF directly mediates Fur-
dependent positive regulation of succinate dehydrogenase in Neisseria meningitidis.” J 
Bacteriol. 2009 Feb;191(4):1330-42. Epub 2008 Dec 5.  
 
Fantappiè L, Metruccio MM, Seib KL, Oriente F, Cartocci E, Ferlicca F, Giuliani MM, 
Scarlato V, Delany I. “The RNA chaperone Hfq is involved in the stress response and 
virulence in Neisseria meningitidis and is a pleiotropic regulator of protein expression.” 
Infect Immun. 2009 May;77(5):1842-53. Epub 2009 Feb 17. 
 
Metruccio MM, Pigozzi E, Roncarati D, Berlanda-Scorza F, Norais N, Hill S, Scarlato 
V, Delany I. “A novel phase variation mechanism in meningococcus driven by a ligand 
responsive repressor and differential spacing of distal promoter elements.” PLoS 
Pathog. 2009 Dec;5(12): e1000710. Epub 2009 Dec 24. 
 
 
 
 
 
 4 
 
 5 
 
Table of Contents 
Title ............................................................................................................................ 1 
Table of Contents ........................................................................................................ 5 
Riassunto ..................................................................................................................... 7 
Abstract ....................................................................................................................... 9 
Introduction .............................................................................................................. 11 
1.1  Meningococcal disease.................................................................................. 11 
1.2  The pathogen................................................................................................. 11 
1.3  Genomes ....................................................................................................... 13 
1.4  Colonization and Invasion ............................................................................. 14 
1.5  Virulence factors ........................................................................................... 16 
1.6  Phase Variation ............................................................................................. 17 
1.7  Vaccines available......................................................................................... 20 
1.8  NadA ............................................................................................................ 21 
1.9  Alpha subunit of RNA polymerase ................................................................ 23 
1.10  MarR family transcriptional regulators .......................................................... 24 
1.11  IHF ............................................................................................................... 26 
Results ....................................................................................................................... 29 
1.12  Phase variation in expression and transcript level of NadA............................ 29 
1.13  RNA polymerase interaction over the nadA promoter.................................... 32 
1.14  IHF interacts with the nadA promoter............................................................ 35 
1.15  Identification of a cis acting element responsible for growth phase regulation38 
1.16  A protein in meningcoccus cell extract binds GPR region.............................. 40 
1.17  Identification of the GPR binding protein ...................................................... 42 
1.18  NMB 1843 interacts with the nadA promoter................................................. 44 
1.19  NadR represses NadA expression .................................................................. 46 
1.20  NadR represses to a different extent different phase variant promoters .......... 48 
1.21  4-hydroxyphenylacetic acid (4HPA) interacts with NadR and derepresses 
NadA expression ........................................................................................... 50 
Discussion .................................................................................................................. 53 
1.22  Three-dimensional MODEL.......................................................................... 56 
1.23  Regulation MODEL ...................................................................................... 58 
Materials and Methods ............................................................................................. 63 
1.24  Bacterial strains and culture conditions.......................................................... 63 
1.25  DNA techniques. ........................................................................................... 64 
1.26  Construction of nadA promoter fusions ......................................................... 64 
1.27  Construction of knockouts............................................................................. 66 
1.28  Expression and purification of the E.coli RNA polymerase α-subunit and N. 
meningitidis NMB1843 protein. .................................................................... 66 
1.29  Western blot analysis..................................................................................... 67 
1.30  Co-over expression of alpha subunit in E. coli ............................................... 68 
1.31  Crude extract preparation, DNA affinity purification of GPR-binding protein 
and Electrophoretic mobility shift assay (EMSA) .......................................... 69 
1.32  RNA preparation and Primer extension ......................................................... 70 
1.33  DNase I footprinting (NMB1843, Neisseria gonorrhoeae   IHF, Escherichia 
coli RNApol and Alpha-sub) ......................................................................... 71 
1.34  MALDI TOF mass spectrometry ................................................................... 72 
References ................................................................................................................. 79 
 
 6 
 
 
 
 
 
 7 
 
Riassunto 
Il rapido adattamento all´ambiente circostante costituisce uno dei requisiti fondamentali 
per i batteri patogeni. La capacitá di alcuni batteri di esprimere determinati geni in 
maniera casuale (variazione di fase), grazie al cambiamento nella lunghezza di sequenze 
semplici ripetute (SSR) durante la replicazione, conferisce alla popolazione batterica 
una varietá che le permette un piú rapido adattamento ai cambiamenti dell´ambiente 
circostante. In questo lavoro si mostra un nuovo meccanismo alla base della “variazione 
di fase” di NadA, un invasina e adesina di Neisseria meningitidis. Il repressore NadR 
contatta due operatori sul DNA posizionati alle estremitá del tratto di sequenze ripetute 
sul promotore di nadA, e contribuisce al diverso livello di espressione in promotori con 
diverso numero di ripetizioni probabilmente a causa della variazione della distanza 
relativa tra i due operatori. Qui si dimostra inoltre che IHF lega tra questi operatori e, 
probabilmente tramite la formazione di una piega del DNA, favorirebbe l´interazione di 
NadR legato all´operatore distale con quello sovrapposto al promotore. L´acido 4-
idrossifenilacetico, un metabolita del catabolismo degli aminoacidi aromatici che viene 
secreto nella saliva, induce l´espressione di NadA inibendo il legame del repressore al 
DNA. Tra i promotori con diverso numero di ripetizioni sono osservabili solo minime 
differenze nei livelli di trascrizione di nadA in assenza di NadR, queste differenze sono 
probabilmente dovute ad un diverso legame della RNA polimerasi sui diversi 
promotori, che porta ad un´alterata attivitá trascrizionale. Questi risultati suggeriscono 
che l´espressione di NadA si trova sotto il controllo di eventi sia casuali che finemente 
regolati in base all´ambiente, entrambi mediati dal repressore NadR, e che questa 
importante adesina potrebbe essere indotta durante la colonizzazione dell´orofaringe, 
dove esplica un ruolo importante nell´adesione e invasione della mucosa. In 
conclusione, la presenza di semplici sequenze ripetute nei promotori, puó essere una 
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strategia sfruttata da alcuni batteri patogeni per modificare casualmente il livello di 
espressione di alcuni geni, pur mantenendo la possibilitá di indurli in presenza del 
segnale specifico. 
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Abstract 
Phase variable expression, mediated by high frequency reversible changes in the length 
of simple sequence repeats, facilitates adaptation of bacterial populations to changing 
environments and is frequently important in bacterial virulence. Here we elucidate a 
novel phase variable mechanism for NadA expression, an adhesin and invasin of 
Neisseria meningitidis. The NadR repressor protein binds to operators flanking the 
phase variable tract of the nadA promoter gene and contributes to the differential 
expression levels of phase variant promoters with different numbers of repeats, likely 
due to different spacing between operators. It is shown that IHF binds between these 
operators, and may permit looping of the promoter, allowing interaction of NadR at 
operators located distally or overlapping the promoter. The 4-hydroxyphenylacetic acid, 
a metabolite of aromatic amino acid catabolism that is secreted in saliva, induces nadA 
expression by inhibiting the DNA binding activity of the NadR repressor. When 
induced, only minor differences are evident between NadR-independent transcription 
levels of promoter phase variants, which are likely due to differential RNA polymerase 
contacts leading to altered promoter activity. These results suggest that NadA 
expression is under both stochastic and tight environmental-sensing regulatory control, 
and both regulations are mediated by the NadR repressor that and may be induced 
during colonization of the oropharynx where it plays a major role in the successful 
adhesion and invasion of the mucosa. Hence, simple sequence repeats in promoter 
regions may be a strategy used by host-adapted bacterial pathogens to randomly switch 
between expression states that may nonetheless still be induced by appropriate niche-
specific signals. 
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Introduction 
 
1.1 Meningococcal disease 
 
Neisseria meningitidis is a strictly human pathogen responsible for meningitis and 
sepsis, two devastating diseases that can kill children and young adults within hours, 
despite the availability of effective antibiotics. The reported annual incidence of 
meningococcal disease varies from 0.5 to 10 per 100,000 persons; however, during 
epidemics the incidence can rise above 1 per 1,000 (Stephens 2009). The case fatality 
rate ranges from 5 to 15%, and up to 25% of survivors are left with neurological 
sequelae (Comanducci, Bambini et al. 2002). 
N. meningitidis colonises the upper respiratory tract in about 25% of the human 
population where it can live as commensal. This carrier state not only provides a 
reservoir for meningococcal infection but can also contribute to establish host immunity 
(Stephens 2009). Furthermore, the human host is the only known reservoir for this 
human-adapted bacterium. For largely unknown reasons, dependent from both host and 
pathogen, in a small subset of carriers, meningococcus can invade the pharyngeal 
mucosal epithelium and, in the absence of bactericidal serum activity, disseminate into 
the bloodstream, causing septicaemia. In a subset of cases, the bacteria can also cross 
the blood-brain barrier and infect the cerebrospinal fluid, causing meningitis.  
 
1.2 The pathogen 
N. meningitidis is a Gram-negative, spherical or kidney-shaped bacillus commonly seen 
in pairs (diplococcus). It is aerobic, non-motile, non-sporulating, usually encapsulated 
and piliated (Figure 1). Traditionally, different strains of N. meningitidis are classified 
on the bases of the composition and antigenic property of their capsule. With this 
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method, 13 serogroups can be distinguish, five of which (A, B, C, W-135 and Y) are 
responsible for virtually all meningococcal disease. Meningococci are further classified 
into serotype and serosubtype, based on antigenic differences in their major outer 
membrane proteins (OMPs), PorA and PorB. However, since this classification is based 
on variation of few genes that are probably under selective pressure, serotyping is not 
suitable for modern epidemiology. A genetic typing system based upon polymorphisms 
in multiple housekeeping genes called Multilocus Sequence Typing (MLST) (Maiden, 
Bygraves et al. 1998), is now the gold standard for molecular typing and epidemiologic 
studies, although does not correlate with antigenic composition of the bacteria which 
remains largely variable among lineages. MLST technique has shown that the majority 
of disease associated isolates cluster into a minority of sequence type (ST) called hyper 
invasive lineage (Maiden 2008). Why hyper virulent meningococcal lineages are more 
pathogenic than others remain still unknown.  
 
Figure 1: ImmunoGold labelling and transmission electron microscopy of Neisseria meningitidis strain. 
Analysis of the strain was performed with antisera raised against NadA adhesin (Scale bars: 200 nm.) 
(Pizza, Scarlato et al. 2000). 
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1.3 Genomes 
Up to now seven N. meningitidis genomes have been sequenced, four disease associated 
and three carriage strains These data show that the meningococcal chromosome is 
between 2.0 and 2.1 mega bases in size and contains about 2000 genes (Parkhill, 
Achtman et al. 2000; Tettelin, Saunders et al. 2000; Bentley, Vernikos et al. 2007; 
Schoen, Tettelin et al. 2009). Mobile genetic elements, including IS elements and 
prophage sequences, make up ∼10% of the genome (Parkhill, Achtman et al. 2000). The 
GC percentage is widely variable along the chromosome, with defined regions of low 
GC content that likely have been acquired by a relatively recent horizontal gene 
transfer. These events are common in N. meningitidis due to its natural transformation 
competence (Maiden 1993). The acquisition of the capsule locus by horizontal gene 
transfer, possibly from Pasteurella multocida or P. hemolytica (Schoen, Blom et al. 
2008), appears to be a major event in the evolution of the pathogenicity of the 
meningococcus (Stephens 2009). Other than the genes encoding for the capsule, no core 
pathogenome has been identified suggesting that virulence may be dependent on 
multiple redundant genes. The most evident characteristic of neisserial genome is the 
high abundance of repetitive DNA sequences which leads to genetic instability, 
facilitating duplication or deletion of regions in the genome, as well as recombination 
(Davidsen and Tonjum 2006). These events characterize the non-clonal behaviour of N. 
meningitidis. 
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1.4 Colonization and Invasion 
The first step in meningococcal colonization is the initial contact with nasopharyngeal 
epithelial cells mediated by Type IV pili, then bacteria proceed to proliferate on the 
surface of human non-ciliated epithelial cells, forming small microcolonies at the site of 
initial attachment (Stephens 2009). After the initial colonization, there is a loss or down 
regulation of the capsule, which sterically masks the outer membrane proteins. This 
event can occur both via regulatory system upon cell contact (Deghmane, Giorgini et al. 
2002), and by selection of low or no-capsule expressing bacteria due to phase variation 
(Hammerschmidt, Muller et al. 1996). Close adherence of meningococci to the host 
epithelial cells is mediated by a variety of possible redundant adhesins, previously 
masked by the capsule. This results in the appearance of cortical plaques and the 
recruitment of factors leading to the formation and extension of epithelial cell 
pseudopodia that internalize the bacteria (Stephens 2009). This intracellular lifestyle can 
give the bacteria the opportunity to evade host immune response, find more available 
nutrients and is also a way to further cross the epithelium and enter the blood stream 
(Stephens 2009). In this new environment meningococcus has to express again the 
capsule, which can prevent antibody and complement deposition (Achtman 1995), is 
anti-opsonic and anti-phagocytic and therefore aids survival in blood (Virji 2009). 
These later steps in invasion of the blood stream and the possible subsequent crossing of 
the blood-brain barrier are still poorly understood. 
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                                                                                                                                   (Virji 2009) 
 
Figure 2: Stages in the pathogenesis of N. meningitidis. N. meningitidis may be acquired through the 
inhalation of respiratory droplets. The organism establishes intimate contact with non-ciliated mucosal 
epithelial cells of the upper respiratory tract, where it may enter the cells briefly before migrating back to 
the apical surfaces of the cells for transmission to a new host. Asymptomatic carriage is common in 
healthy adults in which bacteria that enter the body by crossing the epithelial barrier are eliminated. 
Besides transcytosis, N. meningitidis can cross the epithelium either directly following damage to the 
monolayer integrity or through phagocytes in a ‘Trojan horse’ manner. In susceptible individuals, once 
inside the blood, N. meningitidis may survive, multiply rapidly and disseminate throughout the body and 
the brain. Meningococcal passage across the brain vascular endothelium (or the epithelium of the choroid 
plexus) may then occur, resulting in infection of the meninges and the cerebrospinal fluid (Nassif 1999). 
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1.5 Virulence factors 
The only known virulence factors that characterize pathogenic strains are mainly two: 
the polysaccharide capsule, which is thought to protect meningococci during airborne 
transmission between hosts (Virji 2009), allow survival in the blood as mentioned 
before and may shield bacterial surface from the host immune effectors mechanisms. 
The second principal virulence factors are the long surface proteins that protrude from 
the capsule known as pili. These facilitate first adhesion to host tissues apart from being 
the mediators of DNA uptake (Virji 2009). Pilin of Neisseria is expressed from the pilE 
locus, but homologous recombination between the pilE gene and a number of non-
expressed ‘silent’ pilS genes results in a change in the pilE sequence. These variants 
differ in their transformability, adherence and immunogenicity  (Virji, Alexandrescu et 
al. 1992). Additionally, Neisseria spp. possess host specific iron acquisition 
mechanisms and numerous immune evasion mechanisms such as factor H binding 
protein that is able to downregulate complement deposition (Virji 2009). Close adhesion 
and invasion is mainly mediated by an array of proteins such as opacity proteins (Opc, 
Opa) and other adhesins. These proteins are believed to be responsible for the host 
specificity as well as for tissues within the host (Virji 2009). Host specificity poses a 
problem for developing animal models of the disease, and as a result most of our 
knowledge of the pathogenic mechanisms of Neisseria spp. comes from in vitro 
investigations. Numerous additional apparently minor adhesins (several of which were 
identified by homology searching of the available genomes) are generally expressed at 
low levels during in vitro growth but may be important in in-vivo infections. For 
example, in restricted iron environments, such as might be encountered in vivo, the 
transcriptome of N. meningitidis is considerably altered (Grifantini, Sebastian et al. 
2003) and as a result the minor adhesins may become expressed. Furthermore, several 
adhesins are subject to antigenic variation and/or phase variation, which allow bacteria 
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to generate a broad and variable repertoire of surface structure that facilitates evasion of 
immune effectors mechanisms and adaptation to different niche (Virji 2009). This 
requires a multiplicity of adhesins (redundancy) to maintain colonization (Martin, van 
de Ven et al. 2003; Martin, Sun et al. 2004). Several adhesins may also operate 
simultaneously to increase the avidity of bacterial binding to the cell surface. This is 
often a prelude to internalization into epithelial cells (Griffiths, Bradley et al. 2007), 
which can be another immune evasion strategy.  
 
1.6 Phase Variation 
 
Phase variation is a process that results in differential expression of one or more genes 
and results in two subpopulations within a clonal population: one lacking or having a 
decreased level of expression of the phase variable gene(s) and the other subpopulation 
expressing the gene fully.  In this way the bacterial population can alter its antigenic 
properties. This process is distinct from antigenic variation, however, in which a 
bacterial structure, proteinaceous or otherwise, is consistently produced, but in different 
antigenic forms. In specific cases, phase variation can lead to antigenic variation, for 
example if phase variation affects expression of a lipopolysaccharide (LPS) modifying 
enzyme such as SiaD (Hammerschmidt, Hilse et al. 1996). A key feature of phase 
variation is that the ‘On’ and ‘Off’ phenotypes are interchangeable. Thus, a cell with 
gene expression in the ‘Off’ phase, that is lacking expression, retains its ability to 
switch to ‘On’ and vice versa. The frequency with which the switching occurs can vary 
widely in different systems, ranging from as frequently as one cell in ten per generation 
to as infrequent as one in ten thousand. The occurrence of phase variation thus results in 
a heterogenic and dynamically changing phenotype of a bacterial population. A change 
in the ratio of the two subpopulations could in principle be achieved either through 
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selection for or against a subpopulation, or through regulation of gene expression or of 
the switch frequency (van der Woude 2006).  
Phase variable genes in N. meningitidis are typically associated with the presence of 
repetitive DNA motifs (oligonucleotide repeats and microsatellites) that exhibit high 
mutation rates by a slipped-strand mispairing (SSM) mechanism. The presence of repeat 
units cause a slippage of the synthesis strand over the template strand during replication 
that leads to the addition or the deletion of units in the new born filament (Figure 3) 
(Davidsen and Tonjum 2006). When repeats occur in the coding sequence, the promoter 
region or close to the promoter region, they can change the transcriptional and 
translational state of the gene, leading to an on/off switching of the gene product. In N. 
meningitidis a considerably high quantity of phase variable genes exist, affecting all 
kind of virulence factors or host-pathogen interacting structure such as capsule 
biosynthesis (Hammerschmidt, Muller et al. 1996), pili and pilus modification 
(Rytkonen, Albiger et al. 2004), several surface proteins including Opa, Opc, PorA and 
iron binding proteins (van der Ende, Hopman et al. 1995) (Lewis, Gipson et al. 1999) 
(Martin, van de Ven et al. 2003) (Virji 2009). It has been proposed that in N. 
meningitidis over 100 genes are potentially phase variable (Snyder, Butcher et al. 2001) 
(Martin, van de Ven et al. 2003), whereas for example H. influenzae or E. coli contains 
less than 20 and 10 putative phase variable genes, respectively (Hood, Deadman et al. 
1996) (Blatter et al. 1997). 
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Figure 3 | Mechanisms of meningococcal 
phase variation. The molecular mechanism that 
most often mediates meningococcal phase 
variation is RecA-independent slipped strand 
mispairing of repeats during DNA replication 
or repair. a | Tandem repeats are found either in 
the promoter region of the gene, affecting the 
binding of the RNA polymerase and therefore 
transcription, or in the open reading frame 
(ORF), affecting translation. These repeats can 
be homopolymeric, dipolymeric or can be 
composed of tetranucleotides or greater. The 
different meningococcal loci altered by phase 
variation and the corresponding positions of 
tandem repeats are listed. b | The mutational 
mechanism responsible for phase variation of 
the meningococcal outer-membrane protein 
and adhesin NadA is shown. 
 (1) When 5 TAAA repeats are present upstream of the promoter region, the expression level of NadA is 
high (Feil, Holmes et al. 2001). (2) The AT-rich sequence is prone to strand separation. (3) Subsequent 
mispairing of the TAAA repeats can occur during re-annealing due to slippage of the DNA strands. 
Slippage in the 5′ to 3′ direction as shown leaves an unpaired copy of TAAA (indicated by the asterisks). 
(4) The unpaired TAAA is deleted, and the single-stranded loop is the target of excision-repair processes. 
(5) With a reduction in the TAAA repeat number to four, the expression level of NadA is low (Feil, 
Holmes et al. 2001) (Davidsen and Tonjum 2006). 
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1.7 Vaccines available  
Effective capsular polysaccharide-based vaccines are today available for four of the five 
disease-associated serogroups. For serogroup B that is predominant in many countries, 
especially Europe and North America, no broad effective vaccine is currently available. 
This is due to the identity of the serogroup B capsular polysaccharide with a widely 
distributed human carbohydrate ([2→8]N-acetyl neuraminic acid or polysialic acid), 
which is a self antigen, and therefore, is poorly immunogenic in humans. Furthermore, 
the use of this polysaccharide in a vaccine may elicit autoantibodies (Hayrinen, 
Jennings et al. 1995) (Finne, Bitter-Suermann et al. 1987). 
To overcome these issues, an in-silico genome-based approach, called Reverse 
Vaccinology has been used, allowing the identification of approximately 600 potentially 
surface exposed antigens in N. meningitidis serogroup B (Pizza, Scarlato et al. 2000). 
Among these, candidates that could be expressed in E. coli, shown to be surface 
exposed, capable of inducing bactericidal antibodies in mice, conserved and with low 
heterogeneity in a wide range of meningococcal strains, have been selected for further 
studies (Comanducci, Bambini et al. 2002) (Masignani, Balducci et al. 2003; Welsch, 
Moe et al. 2003). This led to the development of the 5-component vaccine against 
MenB, 5CVMB, which combines five antigens: GNA 2132 (Welsch, Moe et al. 2003), 
factor H-binding protein (FHBP) (Masignani, Comanducci et al. 2003) (Fletcher, 
Bernfield et al. 2004) (Madico, Welsch et al. 2006), the invasin NadA (Capecchi, Adu-
Bobie et al. 2005) (Comanducci, Bambini et al. 2002), GNA 1030 and GNA 2091 
(Rinaudo, Telford et al. 2009). 
Study of regulation of expression of these genes could allow us not only in the better 
understanding of the pathogenesis of this bacterium, but has also fundamental 
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implications in the Meningococcal B vaccine coverage. Among the five antigens that 
compose the MenB vaccine, this thesis focuses on the regulation of NadA expression. 
 
1.8 NadA 
Bioinformatic analysis of the genome of a virulent N. meningitidis B strain (Tettelin, 
Saunders et al. 2000) allowed the identification of previously unknown surface proteins 
(Pizza, Scarlato et al. 2000), among which is the 45-kDa N. meningitidis Adhesin A 
(NadA). Structure prediction and homology comparison suggests that NadA belongs to 
the group of oligomeric coiled-coil adhesins (OCA) such as YadA of Yersinia 
enterocolitica and UspA2 of Moraxella catarrhalis (Comanducci, Bambini et al. 2002). 
Within these homotrimeric outer-membrane proteins, three structural regions are 
present: a conserved –COOH terminal membrane anchor, having a β structure; an 
intermediate coiled-coil stalk comprising a leucine zipper; and a –NH2 terminal region, 
forming the binding site(s) for target cell receptors (Hoiczyk, Roggenkamp et al. 2000). 
NadA is a risk factor for the development of meningococcal disease, as it was found in 
50% of N. meningitidis strains isolated from patients and in only 5% of strains from 
healthy individuals (Comanducci, Bambini et al. 2004). NadA has been implicated in 
the mucosal colonization by N. meningitidis, as its expression enhances bacterial 
adhesion to and invasion of mucosal cells (Capecchi, Adu-Bobie et al. 2005). NadA has 
also been implicated in interaction and stimulation of monocyte, macrophage and 
dendritic cells during N. meningitidis infection (Franzoso, Mazzon et al. 2008). 
Little is known about the factors or mechanisms regulating expression of the NadA 
protein. Its expression was shown to exhibit growth-phase dependent behaviour with 
levels reported to be maximal in the stationary growth phase of all strains tested 
(Comanducci, Bambini et al. 2002). Furthermore, the expression of NadA is phase 
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variable and a tetranucleotide tract (TAAA) upstream of the nadA gene promoter has 
been demonstrated to control this phenomenon (Martin, van de Ven et al. 2003). 
The phase variable tract of nadA is distally located upstream of the nadA promoter, 
unlike the phase variable repeat tracts found in the porA, fetA, and opc genes where the 
unstable homopolymeric stretches are found between the -10 and the -35 promoter 
elements and are thought to result in altered sigma-factor binding (Sarkari, Pandit et al. 
1994) (van der Ende, Hopman et al. 1995) (Carson, Stone et al. 2000). The phase 
variation mechanism for the nadA gene is unique in that all phase variable promoter 
variants result in the expression of full length protein, which is unlike the case when 
repeats are located in coding regions (frame-shift mutation leading to generation of stop 
codons) or when suboptimal -10 and -35 promoter spacing precludes or affects 
promoter recognition or activation. The frequency of phase variation of nadA has been 
experimentally estimated as ca. 4.4 x 10-4 (Martin, van de Ven et al. 2003), creating 
variants where changes in the repeat number result in promoters with low, medium or 
high activity. The transcriptional regulators Fur and IHF were implicated in the control 
of nadA promoter activity from the specific binding of both proteins to the nadA 
promoter and from the analysis of mutants deleted for multiple IHF- and Fur-binding 
sites (Martin, Makepeace et al. 2005). Moreover, it has been reported that loss or gain of 
a tetranucleotide repeat affects the binding of the IHF regulatory protein to the nadA 
promoter in vitro, and this was proposed to be responsible for the modulation of 
transcription of nadA in vivo (Martin, Makepeace et al. 2005). Nonetheless, the precise 
mechanism governing transcriptional regulation of nadA remains unclear and the 
inferred role of IHF or Fur and their involvement in phase variation of nadA expression 
remain to be elucidated. However, a novel regulator of NadA expression has recently 
been identified which was shown to repress NadA expression (Schielke, Huebner et al. 
2009).   
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In this work we will show results on the interactions on nadA promoter region, and the 
involvement in its transcriptional regulation, of three different regulatory factors: the α-
subunit of RNA polymerase, a MarR family transcriptional regulator named NadR 
(NMB1843) and the architectural protein IHF. 
 
1.9 Alpha subunit of RNA polymerase 
In recent years, it has become clear that promoter recognition by bacterial RNA 
polymerase (RNAP) involves interactions not only between core promoter elements and 
the sigma subunit, but also between a DNA tract, called UP element, upstream of the 
−35 sequence and the RNAP α subunit (Hawley and McClure 1983) (Ross, Gosink et 
al. 1993) (Blatter, Ross et al. 1994). The best-characterized UP element is in the rrnB P1 
promoter, in which the sequence determinants are located between positions −40 and 
−60 with respect to the transcription start site (Rao, Ross et al. 1994), and UP element-
α-subunit interactions facilitate initial binding of RNAP and subsequent step(s) in 
transcription initiation (Rao, Ross et al. 1994) (Strainic, Sullivan et al. 1998). A 
consensus UP element sequence derived from binding-site selection experiments, 
consists almost exclusively of A and T residues and increases promoter activity >300-
fold (Estrem, Gaal et al. 1998). Each RNAP α subunit consists of two domains 
connected by an unstructured and flexible linker (Blatter, Ross et al. 1994) (Jeon, 
Yamazaki et al. 1997). The 28-kD aminoterminal domain (αNTD) is responsible for 
dimerization of α and for interaction with the remainder of RNAP (Igarashi and 
Ishihama 1991; Busby and Ebright 1994). The 8-kD carboxy-terminal domain (αCTD) 
is responsible for interaction with the UP element (Blatter, Ross et al. 1994) and with a 
number of transcriptional activators (Igarashi and Ishihama 1991) (Busby and Ebright 
1999) (Savery, Lloyd et al. 1998). The αCTD residues most crucial for DNA interaction 
are nearly invariant in bacteria (Gaal, Ross et al. 1996) (Murakami, Fujita et al. 1996), 
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and therefore the DNA sequences recognized by α are also likely to be highly 
conserved. The interdomain linker presumably accounts for the ability of αCTD to 
interact with DNA and/or activator molecules at different locations upstream of the −35 
element (Newlands, Josaitis et al. 1992) (Blatter, Ross et al. 1994) (Murakami, Owens et 
al. 1997) (Belyaeva, Rhodius et al. 1998) (Hochschild and Dove 1998) (Law, Savery et 
al. 1999).  
 
1.10 MarR family transcriptional regulators  
The MarR (multiple antibiotic resistance regulator) family of prokaryotic transcriptional 
regulators includes proteins critical for control of virulence factor production, bacterial 
response to antibiotic and oxidative stresses and catabolism of environmental aromatic 
compounds. MarR proteins exist as homodimers in both free and DNA-bound states. 
Sequence specific DNA-binding to palindromic or pseudopalindromic sites is mediated 
by a conserved winged helix fold and, for numerous homologs, this association is 
attenuated by specific anionic lipophilic ligands. The mechanism of ligand-mediated 
allosteric control of DNA binding is unique amongst prokaryotic transcriptional 
regulators in that the DNA- and ligand binding domains almost completely overlap in 
the residues involved. Proteins belonging to this family of transcriptional regulators 
serve physiological roles as sensors of changing environments, a capacity particularly 
critical for pathogenic bacteria. Homologs of MarR are distributed throughout the 
bacterial and archaeal domains and it has been suggested that the MarR family is one of 
nine families of transcription factors to have evolved before the divergence of these 
domains over 3 billion years ago (Perez-Rueda and Collado-Vides 2001) (Perez-Rueda, 
Collado-Vides et al. 2004). Transcriptional regulation by MarR proteins is modulated 
by specific anionic lipophilic (usually phenolic) compounds, which attenuate the ability 
of MarR homodimers to bind their cognate DNA sequences. The gene encoding each 
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MarR homolog is generally part of a gene cluster containing the gene(s) under its 
regulation (with a couple of notable exceptions) and in some cases, the MarR homolog 
is encoded in its regulated operon. The locations of the MarR binding sites often overlap 
the –35 and/or –10 promoter elements of their target genes, suggesting that repression is 
achieved by steric inhibition of RNA polymerase binding to the promoter. However, the 
homolog HpaR from E. coli likely represses transcription by blocking promoter escape 
by RNA polymerase, while SlyA from Salmonella typhimurium has been suggested to 
prevent open complex formation and the binding sites of other homologs suggest that 
they impede transcriptional elongation (Stapleton, Norte et al. 2002) (Galan, Kolb et al. 
2003). Cooperative binding to closely spaced recognition sequences has been 
demonstrated for OhrR from Bacillus subtilis and may occur for other MarR homologs, 
as well (Evans, Adewoye et al. 2001) (Fuangthong and Helmann 2002) (Stapleton and 
Taylor 2002). The physiological roles of MarR proteins can be classified into three 
general categories with some proteins serving multiple regulatory roles: 1) regulation in 
response to environmental stress, 2) regulation of virulence factors, and 3) regulation of 
aromatic catabolic pathways (Wilkinson and Grove 2006).  A MarR homolog has been 
characterized from N. gonorrhoeae that likely mediates the resistance of this organism 
to antimicrobial hydrophobic agents. FarR represses its own transcription and that of the 
distally located farAB operon of N. gonorrhoeae, which encodes an efflux pump that 
exports host-derived antimicrobial agents such as long-chain fatty acids (Lee, 
Rouquette-Loughlin et al. 2003).  
Similarly, HpaR from E. coli represses transcription of the hpa-meta operon which 
encodes genes for the catabolism of 4-hydroxyphenylacetic acid and this repression is 
relieved by 4-hydroxyphenylacetic acid and structurally similar compounds (Galan, 
Kolb et al. 2003). 
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1.11 IHF 
For macromolecular complexes built on a DNA template, the active components are 
often insufficient to generate the proper architecture, and accessory factors are needed. 
Integration host factor (IHF) is a small heterodimeric protein that specifically binds to 
DNA and functions as an architectural factor in many cellular processes in prokaryotes 
(Rice, Yang et al. 1996).  
IHF is composed of two subunits, which share about 25% homology. The alpha-subunit 
is approximately 11kDa and the beta-subunit about 9.5kDa in size. The structure of the 
hetero-dimeric protein has been resolved and can be described as a body with 
protruding flexible arms that can be inserted into the minor groove of DNA (Rice, Yang 
et al. 1996) (Swinger and Rice 2004). A typical specific IHF binding site is 
approximately 30 bp. The 3’ region is conserved (matching the consensus 
(A/T)ATCAANNNNTT(A/G) (where N=any nucleotide)), whereas the 5’ region is not 
conserved, although commonly A/T rich (Goodrich, Schwartz et al. 1990) (Luijsterburg, 
Noom et al. 2006). 
Although first discovered as a host factor for bacteriophage lambda integration, IHF 
assists in many processes that involve higher order protein–DNA complexes: e.g., in 
replication, where it binds to oriC; in transcriptional regulation, where it binds upstream 
of many σ54-dependent promoters; and in a variety of site specific recombination 
systems (Rice, Yang et al. 1996) (Goosen and van de Putte 1995). IHF’s primary 
function appears to be architectural, i.e., introducing a sharp bend in the DNA that 
facilitates the interaction of other components in a nucleoprotein array (Figure 4). 
Where tested, IHF can be at least partially replaced by heterologous DNA-bending 
proteins or by intrinsically bent DNA (Goodman, Nicholson et al. 1992) (Molina-Lopez, 
Govantes et al. 1994) (Perez-Martin, Timmis et al. 1994) (Segall, Goodman et al. 1994) 
(Parekh and Hatfield 1996) (Rice, Yang et al. 1996). 
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Interestingly, IHF has been shown to enhance transcription levels from pilEp1 promoter 
in N. gonorrhoeae with the possible involvement of two UP elements (Fyfe and Davies 
1998). Moreover, in Pseudomonas putida, IHF binding mediate a topological switch 
that governs the positioning of RNA polymerase alpha subunit over 2 distinct UP 
elements in Pu promoter (Macchi, Montesissa et al. 2003). Finally it has been shown 
that IHF can bind over nadA promoter in N. meningitidis (Martin, Makepeace et al. 
2005). 
 
 
 
 
 
 
 
 
 
 
 
 
(Rice, Yang et al. 1996) 
 
Figure 4. Complex of IHF with Site H91N. (A) Front view. The alpha subunit is shown in white; beta, 
pink. The consensus sequence is highlighted in green and interacts mainly with the arm of alpha and the 
body of beta. The yellow proline at the tip of each arm (P65a/P64b) is intercalated between bp 28 and 29 
on the left side and 37 and 38 on the right. 
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Results 
 
1.12 Phase variation in expression and transcript level of NadA 
 
Previous analysis of NadA expression in several meningococcal isolates indicated that 
its expression is controlled by variation in the number of tetranucleotide repeats 
(TAAA) upstream of the core promoter (Martin, van de Ven et al. 2003) and that the 
protein is maximally expressed in stationary growth phase (Comanducci, Bambini et al. 
2002).  
Figure 5A shows key elements of the nadA promoter sequence, identified in this work 
through footprinting analysis (shaded boxes), as well as positions of different deletions 
in the promoter (ΔP from 2 to 5). 
First of all, to confirm this data, we analyse NadA expression level in different N. 
meningitidis strain harbouring different numbers of repeats in the nadA promoter. As 
shown in the western blot of Figure 5B, from overnight bacteria grown on plates, NadA 
is expressed at low level in MC58 strain (carrying 9 TAAA repeats upstream of the 
promoter), intermediate level in 961-5945 and ISS838 (having 12 and 6 repeats, 
respectively) and high level in strains BZ83 and 5/99 (5 and 8 repeats, respectively). 
In order to rule out any possible effect in NadA expression due to strain differences we 
decided to study transcriptional regulation of the nadA promoter generating isogenic N. 
meningitidis MC58 strains, carrying a complete range of nadA phase variant promoter 
fusions with a different number of repeats and determined the relative level of the 
transcripts from these promoters. Steady state levels of nadA transcript were measured 
by quantitative primer extension analyses in cells grown to the mid log and the 
stationary growth phases. 
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As is evident from Figure 5C, the transcript level from the nadA promoter gives a quasi 
periodic pattern with 4, 9 and 12 repeats resulting in the lowest transcription, 7, 8 and 
10 has instead the highest transcript level, and 5, 6, 11, 13 and a promoter mutant 
lacking TAAA repeats (pΔ) giving varying intermediate levels. These results mirror the 
NadA expression levels seen in the five strains of panel A, strongly suggesting that 
different expression levels could be due only to differences in TAAA repeats number. 
Furthermore, each phase variant promoter exhibits a certain degree of growth-phase 
dependent transcription, with a maximum level of transcription in stationary growth 
phase from promoters harbouring 7, 8 and 10 repeats. 
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Figure 5: The PnadA promoter and transcript level. A) Schematic diagram of the PnadA elements. DR, direct 
repeat (border of region of horizontal transfer); GPR, growth phase regulatory region; ΔP2-ΔP5 indicates 
the nucleotide positions of the 5’ deletion mutants (Figure 8C). The nucleotide sequence of the promoter 
is shown with the regions bound and protected in DNase I footprinting experiments shaded according to 
the regulatory proteins tested in vitro: light grey, RNAP α-subunit; white, IHF; dark grey, NadR. (B) 
Western Blot analysis of the level of expression of NadA in wild type strains 5/99, BZ83, ISS838, 961-
5945 and MC58 carrying nadA promoters with 8, 5, 6, 12, and 9 repeats, respectively. Cells were 
recovered from overnight culture on plates and 5 µg of total protein were loaded on SDS-PAGE, blotted 
and stained with anti-NadA polyclonal antiserum. (C) Transcription of each phase variant promoter is 
growth phase responsive. Cultures of MC-PΔ, MC-P2(x4), MC-P2(x5), MC-P2(x6), MC-P2(x7), MC-
P2(x8), MC-P2(x9), MC-P2(x10), MC-P2(x11), MC-P2(x12), MC-P2(x13) strains, carrying single copy 
transcriptional fusions of the phase variant nadA promoter with a defined number of copies of the 
tetranucleotide repeat (TAAAxN) and the repeated tract deleted (Δ) (Table II), were grown to mid-log or 
stationary growth phase and total RNA was prepared. Quantitative primer extension was performed as 
described in materials and methods. Autoradiographs of a representative experiment are shown as well as 
the quantification of transcript levels as determined by phosphorimaging.  
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1.13 RNA polymerase interaction over the nadA promoter 
 
The repeated tract in the nadA promoter, due to its high content in AT and its 
localization upstream the -35 sequence, can be a perfect candidate as an UP-element, 
thus influencing transcription through interaction with the α−subunit of the RNA 
polymerase (RNAP). In order to gain insight into the interaction of the polymerase with 
nadA promoter region we performed footprinting experiments using the holoenzyme 
and three radioactively labelled phase variant promoters, corresponding to low (9 
repeats), medium (6 repeats), and high (7 repeats) transcript level. 
As expected, addition of RNAP to the nadA promoter probe resulted in a characteristic 
footprint over the core promoter spanning from -37 to +17, as well as protecting two 
other regions, one directly upstream of the core promoter spanning positions -43 to -76, 
partially overlapping the TAAA tract, and the second distally upstream spanning from -
116 to -154 with respect to the probe with 9 repeats (Figure 6A). Notably, at least three 
hypersensitive bands appear between the two protected regions upstream of the 
promoter, suggesting that there is a distortion in the DNA of this region upon binding of 
the RNAP. Interestingly, no relevant differences in the protected regions are visible 
between the phase variant promoters tested, with the exception of the PΔ promoter 
variant, deleted of the TAAA tract, in which the region just upstream the core promoter 
is not protected anymore (Figure 6B). 
As both upstream protected areas are AT-rich regions, a typical feature of UP-like 
elements bound by the C-terminal region of the α-subunit of RNAP to enhance 
transcription (Ross, Aiyar et al. 1998) (Estrem, Gaal et al. 1998), we decided to verify 
such a hypothesis in vitro by DNase I footprinting using the purified α-subunit of the 
RNAP.  
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Results showed a specific binding of the α protein over the TAAA repeats at low protein 
concentration (Figure 6A). Upon addition of increasing amounts of the α protein, this 
protected area extended both to downstream and upstream regions, including regions 
spanning positions -43 to -76 and -116 to -154 protected by the holoenzyme (Figure 
6A).  
Furthermore, because the nadA promoter is recognised and transcribed from the same 
+1 in E. coli (data not shown), we decided to test whether the α-subunit of RNAP could 
play a role in the transcription of PnadA in this system. We measured promoter activity 
of a PnadA-gfp fusion (on plasmid pGX-nad- gfp) in an E. coli strain over-expressing 
either a wild type α-subunit (RpoA) or a C-terminally truncated α–subunit (RpoAΔ256) 
of E. coli. Expression of the PnadA-gfp fusion in the strain over-expressing the wild 
type α-subunit gave 6393 ± 254 Units (fluorescence normalized with OD600), while in 
the strain over-expressing the α truncated version, the activity was reduced by over 50% 
giving 2867 ± 63 Units. No reduction in promoter activity was apparent when the PΔ 
nadA fusion was co-expressed with the α or truncated α subunit (Figure 6C).  
These data suggest that the incorporation of a complete α-subunit into the RNAP allows 
maximum transcriptional activity at PnadA, possibly through contacts of the C-terminal 
region of the α-subunit to upstream DNA regions containing AT-rich sequences sharing 
similarities to an UP element. However, the roles of the distal region of interaction with 
the α-subunit, as well as possible effects of different DNA topology removing the 
TAAA tract, remain to be elucidated.  
 
 34 
 
 
Figure 6: RNA polymerase interaction over NadA promoter. (A) DNase I footprinting of RNAP or the α-
subunit of RNAP to the indicated nadA promoter probe. The probe was incubated with 0, 0.25, 0.5, 1, 2, 
4, and 5 U of RNAP (lanes 1-7) or 0, 0.17, 0.68, 2.7, 5.5, 11 µM of purified α-subunit (lanes 8-13). (B) 
DNase I footprinting of RNAP to four different nadA phase variant promoters, the probes were incubated 
with 0, 2, 4 and 6 U of RNAP (lanes 1-4). Black bars indicate RNAP core enzyme protection, whereas 
grey bars indicate α-subunit of RNAP protection. (C) Fluorescence measurements of E. coli expressing 
PnadA-GFP fusions and over-expressing either wild type α-subunit or a C-terminally truncated α-subunit 
(plaw2 and plaw2D respectively). Bacteria were grown at mid log growth phase and then fluorescence 
was measured normalized with OD600. Numbers are given as percentage of fluorescence with respect to 
strains over-expressing wild type α-subunit. 
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1.14 IHF interacts with the nadA promoter 
 
In vitro DNA binding assays suggested that regulation of nadA expression is under the 
control of the Fur and IHF regulatory proteins and that loss or gain of TAAA repeats 
could affect IHF binding, thus accounting for the different promoter activity of the 
phase variants (Martin, Makepeace et al. 2005) Moreover, IHF seems to be involved in 
allowing interaction of distal UP-elements with the RNAP in pilEp1 promoter of N. 
gonorrhoeae and in pu promoter of P. putida (Fyfe and Davies 1998) (Bertoni, Fujita et 
al. 1998) respectively. An involvement of IHF in nadA regulation, could also explain 
how a DNA region distally upstream (from -116 to -154) can interact with the α-subunit 
of the RNAP bound to the core promoter.  
We mapped the precise location where Fur and IHF bind to the nadA promoter. DNase 
I footprinting was performed with the purified proteins and the same phase variant 
promoters used for RNAP experiments shown in Figure 6. 
Addition of increasing amounts of a recombinant Fur protein (0.013-3.2 µM) showed a 
region of protection at 3.2 µM Fur concentration (data not shown). This protection 
overlaps the translational start site (+79) spanning from +61 to +96. Moreover, no 
differences in nadA transcription were detected in a Fur null mutant background when 
compared with the wild type strain, nor in response to changing iron concentrations 
(data not shown). Therefore, the observed in vitro binding of Fur to the nadA promoter 
appears to have no correlation with in vivo regulation of transcription by Fur in response 
to iron. 
On addition of 43 or 172 nM of the IHF heterodimer to the binding reactions resulted in 
a similar region of protection in all three phase variant probes (Figure 7). IHF binds 
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upstream of the distal border of the TAAA tract and the protection spans the first 5 
repeats, from -103 to -65 with respect to the promoter with 9 repeats (Figure 7). 
Accordingly, no binding could be detected in PΔ promoter variant in which the TAAA 
tract was deleted (Figure 7). Notably, variations of the number of repeats resulted in no 
differential binding of IHF in these experimental conditions. 
IHF is well known for its ability to bend DNA by up to 180° (Rice, Yang et al. 1996) 
and this property may permit looping of the DNA and the interaction of regulators at 
distal operators and the transcriptional machinery over the promoter.  
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Figure 7: IHF interaction over NadA promoter. DNase I footprinting of IHF protein to three different 
phase variant nadA promoters with 9, 6 and 7 repeats corresponding to low, medium and high transcript 
level in vivo, respectively, and the PΔ mutant PnadA variant with a deletion of the TAAA repeated tract. 
To 20 fmoles of each radioactively labelled probe, 0, 43 and 172 nM (lanes 1-3) of IHF heterodimer were 
added. Relevant regions are marked and numbers correspond to nucleotide positions with respect to the 
transcriptional start site of a promoter with 9 repeats.  
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1.15 Identification of a cis acting element responsible for growth 
phase regulation 
Transcription from the nadA promoter is regulated during growth, as shown in the 
primer extension experiment shown in Figure 8B, which was performed on total RNA 
extracted at different time points from MC58 growing cells. As shown, nadA is 
transcribed maximally in late logarithmic and stationary phase. Unlike adenylate kinase 
gene that, as many other housekeeping genes, is less transcribed entering in stationary 
phase due to a general slowdown in the bacterial metabolism. 
In order to identify regulatory regions within the PnadA promoter we created a range of 
deletion mutants in N. meningitidis MC58 strain, and measured the transcript level from 
cells grown to the mid-log and stationary growth phases (Figure 8C and 8D). While 
deletion of nucleotide sequences upstream of -170 with respect to the +1 transcriptional 
start site had little or no effect on the level of transcript (promoter P2 versus P1), 
promoter mutants lacking the region between -170 and -108, (P3 or P4) resulted in a 
significant increase in transcription during log phase. The same results have been 
obtained for promoters harbouring 11 repeats (data not shown). This finding suggests 
that the growth-phase dependent regulation is due to a repression of expression in log 
phase, more than an induction in stationary phase. Accordingly, removal of the TAAA 
tract did not alter the growth-phase regulation of the resultant mutants (P4 versus P3, or 
PΔ versus P2). Therefore, we have identified a distal upstream cis-acting region that we 
call the GPR region (for growth phase regulatory), which is responsible for repression 
of transcription from PnadA in log phase, possibly upon binding of a repressor protein.  
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Figure 8: Identification of a cis-acting element of the nadA promoter determining growth phase 
regulatory effects (the GPR region). (A) Growth curve of MC58 strain. Bacteria from an overnight plate 
were inoculated at an OD600 of 0.05 in GC liquid media and grown for 7 hours. Numbers indicate the 
points in which RNA samples were taken. (B) Primer extension analysis on nadA and adk transcript from 
total RNA extracted at time-points indicated in panel A. (C) Schematic representation of the mutant nadA 
promoter variants (based on the MC58 nadA promoter with 9 repeats) present in single copy 
transcriptional fusion in the MC58 background in the strains, MC-P1, MC-P2, MC-P3, MC-P4, MC-P5, 
MC-PΔ. The numbers indicate nucleotide positions with respect to the +1 transcriptional start site. DR, 
direct repeat; GPR, growth-phase regulatory region; Δ, deletion of the TAAA repeats. (D) Transcription 
from the mutant promoter variant fusions in log and stationary phases. The MC-P1, MC-P2, MC-P3, MC-
P4, MC-P5, MC-PΔ strains were grown to mid-log and mid-stationary growth phase and total RNA was 
prepared from each sample. Quantitative primer extension was performed as described in materials and 
methods. Autoradiographs of a representative experiment are shown as well as the quantification of 
transcript levels. Similar results were found for deletion variants carrying 11 TAAA repeats (data not 
shown). 
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1.16 A protein in meningococcus cell extract binds GPR region 
 
To assess whether a repressor factor could bind the GPR region we analysed crude cell 
extracts of the MC58 strain for the ability to retard a radioactively labelled GPR probe 
in Electrophoretic Mobility Shift Assays (EMSA). Addition of 15 µg of MC58 extracts 
resulted in a complete shift of the GPR probe, which could be outcompeted with cold 
GPR DNA but not with non-specific competitor (Figure 9A). We also found that the P5 
promoter probe spanning from -9 to +79 of the PnadA promoter was specifically retarded 
(lane 11, Figure 9A) by MC58 extracts but not an unrelated intergenic region (Pcon) 
used as negative control. 
We further characterize the nature of this binding factor performing EMSA after 
incubation of the cell extract with different proteases or at different temperatures. Upon 
treatment with 5 µg of Trypsin or ProteinaseK for 2 hours we were able to completely 
abolish the binding activity of the cell extract (Figure 9B, lanes 4 and 6). Furthermore, 
incubating the cell extract for 30 minutes at 60 or 100 °C has the same effect of protease 
treatment, probably due to protein denaturation, whereas 30 minutes at 40 °C does not 
seem to alter the binding activity. Then, we fractionate cell extract using sequential 
ammonium sulphate precipitation, with increasing salt concentration. The binding 
activity is retained only in the 70% precipitated fraction, in which there is an enrichment 
of small proteins. These data taken together suggest that the GPR binding factor could 
be a small protein relatively heat-resistant. 
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Figure 9: A protein in meningococcus cell extracts specifically binds the GPR region. (A) Binding 
activity towards the nadA promoter in cell extracts of MC58. Cell extracts were prepared from mid-log 
cultures of MC58 and increasing quantities were incubated with a radioactively labelled DNA probe 
consisting of the GPR region (-170 to -108) or P5 (- 9 to +79) or an unrelated intergenic region Pcon as 
negative control and submitted to EMSA analysis. To ca. 80 fmoles of radioactively labelled probe, 0, 
0.2, 0.6, 1.8, 5.0, 15 µg of cell extract in lanes 1-6 were added, respectively; 0 µg in lanes 10 and 12; and 
15 µg in lanes 7-9, 11 and 13, were added; and 130, 400, and 1000 fmoles of cold GPR probe in lanes 7, 
8, and 9 were added as specific competitor. (B) Different treatments of the cell extract in order to 
characterize the nature of the binding activity. Ten µg of cell extracts were incubated with 5 µg of 
Trypsin or Proteinase K either for 30 minutes or 2 hours (lanes 3-6), or for 30 minutes at 40, 60 and 100 
°C (lanes 9-11 respectively) and then subjected to EMSA assay. To fractionate cell extract we 
sequentially precipitated it with ammonium sulphate salts at 20, 40, 60 and 70% (lanes 15-22, 
respectively) and then perform EMSA assay using 2 µg (+) or 4 µg (++) of each fraction. 
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1.17 Identification of the GPR binding protein 
 
To identify the GPR binding factor we performed DNA affinity purification using the 
biotinylated GPR region as ‘bait’ and streptavidin coated magnetic beads (Figure 10A). 
After incubation of the biotinylated GPR probe with the extract and the addition of 
streptavidin coated magnetic beads, the sample was washed and the GPR binding factor 
eluted with high salt. Each step of the purification was then analyzed for GPR binding 
activity through EMSA. Figure 10B shows as the binding activity is successfully eluted 
from the beads only in presence of biotinylated GPR DNA and not in the negative 
control (same purification performed with a non biotinylated GPR DNA). The eluted 
fraction was digested with trypsin, and the resulting peptides were analyzed by MALDI-
TOF mass spectrometry. Four of the seven major ions could be assigned to tryptic 
peptides derived from the NMB1843 protein (Figure 10C and 10D). The other three 
peaks could be assigned to bovine serum albumin which was added in the purification 
step to block non-specific interaction. To confirm the interpretation, the major parental 
ions were fragmented. Spectra of fragmentation were consistent with the expected 
NMB1843 amino acid sequence (data not shown). We call this protein that binds the 
GPR region of the nadA promoter NadR. The nadR gene encodes a transcriptional 
regulator of the MarR family of repressors, is a homologue of FarR, the repressor of the 
fatty acid resistance efflux pump of N. gonorrhoeae (Lee and Shafer 1999) (Lee, 
Rouquette-Loughlin et al. 2003) and was recently implicated as a repressor of nadA 
(Schielke, Huebner et al. 2009). We rename the meningococcal homologue NadR as, 
unlike the FarR protein, it does not regulate the fatty acid efflux pump in 
meningococcus (Pigozzi E, personal communication) and, therefore, is not involved in 
fatty acid resistance. 
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Figure 10: Identification of the GPR binding protein. (A) Cartoon showing the DNA affinity purification 
system. (B) To monitor the purification efficiency, every fraction was subjected to EMSA assay using an 
unbiotinylated GPR probe as negative control (lanes 4, 6, 8 and 10). FT: flow trough, W1 and W2: 
washes, Elu: eluted fraction. (C) The peptide mass fingerprint spectrum of one µl of the eluted fraction 
after DNA affinity purification of the binding factor of the GPR region. Four of the major ions, labelled, 
could be assigned to tryptic peptides (positioning of the amino acids indicated above) of the NadR 
transcriptional regulator protein. In addition, BSA, that was added during the process of purification, was 
eluted from the column, since 3 major signals observed in the spectrum corresponded to BSA tryptic 
peptides (marked with an asterisk). (D) The amino acid sequence of the NMB1843 (NadR) protein 
showing the peptides that were identified by MS in bold and underlined. 
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1.18 NMB 1843 interacts with the nadA promoter 
 
We amplified and cloned the nadR gene (NMB1843) from the MC58 genome into an 
expression plasmid and expressed and purified a recombinant form of the protein with 
an N-terminal Histidine tag. We performed DNase I footprinting analysis with the NadR 
protein and a radioactively labelled probe consisting of the entire nadA promoter. Figure 
11A shows the autoradiogram of the results. On addition of increasing amounts of 
NadR recombinant protein, three regions of protection of the nadA promoter are visible. 
Two appear on addition of 30 nM of NadR protein: the first (OpI) spanning from -139 
to -119 and the second (OpII) spanning from -15 to +7 and, therefore, within regions of 
the GPR and P5 probes that were previously shown to be bound by the MC58 extracts 
as well as a third region (OpIII) spanning the TAAA tract from -55 to -85. EMSA 
analysis confirmed that NadR exhibits high affinity for the GPR and P5 operator regions 
and exhibits a lower affinity for the TAAA tract. These observations were supported by 
EMSA analysis with a probe spanning the entire PnadA promoter as three differential 
protein-DNA complexes were formed, most likely following sequential binding of the 
protein to the operators located within the PnadA probe (Figure 11B).  
To confirm that NadR is the GPR-binding factor, we generated a deletion nadR mutant 
by substituting the gene with an antibiotic resistance marker. Cell extracts derived from 
the N. meningitidis Δ1843 mutant no longer possessed binding activity towards the GPR 
probe (Figure 12A). 
From this analysis we conclude that NadR encodes the GPR-binding factor that binds to 
three operators; two high affinity operators OpI and OpII within the distal GPR region 
and overlapping the nadA promoter, respectively, and a lower affinity operator OpIII 
which spans the TAAA repeat tract. 
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Figure 11: The NadR repressor binds specifically to three operators in the nadA promoter. (A) DNase I 
footprinting analysis with purified NadR on the nadA promoter with 9 repeats. The NadR protected 
regions are indicated (OpI-III) and numbers represent the nucleotide positions with respect to the 
transcriptional start site. The size of protected regions ranges from 20 bp (OpI and OpII), and 30 bp 
(OpIII), a size compatible with the binding of a protein dimer. Binding reactions contained 40 fmoles of 
probe radioactively labelled at one extremity and 0, 7.5, 15, 30, 60, 120 nM of NadR purified dimer 
(lanes 1-6, respectively). (B) EMSA with radioactively labelled GPR, TAAA and P5 probes containing 
the individual OpI, OpIII and OpII operators, respectively, or the entire P2 nadA promoter spanning from 
-170 to +79 with increasing concentrations of recombinant NadR protein as indicated. The retarded 
migration of protein DNA complexes are indicated with asterisks. 
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1.19 NadR represses NadA expression 
 
To further study the role of NadR in regulating NadA expression, and its possible 
involvement in mediating differential expression from phase variant promoters, we 
generated isogenic knockouts in five representative strains bearing different numbers of 
tetranucleotide repeat in their nadA promoter which correlate to high (8 repeats, 5/99) 
and low (9 repeats, MC58), as well as three intermediary (5 repeats, BZ83; 6 repeats, 
ISS838, and 12 repeats, 961-5945) levels of NadA expression. We evaluated by 
Western Blot the NadA and NadR expression level in the wild type and Δ1843 
meningococcal strains. The wild type strains showed, as expected, levels of NadA 
expression that can be associated with transcript levels of the nadA phase variant 
promoter they bear, and NadR was constitutively expressed in each strain (Figure 12B, 
WT). Each of the knockout strains exhibits higher levels of NadA expression than their 
respective wild type strain indicating that NadR represses nadA expression in each 
strain (Figure 12B WT vs Δ1843). Surprisingly, the mutation of NadR results in almost 
equivalent levels of NadA between the knockout strains, although the 5/99-Δ1843 and 
BZ-Δ1843 still exhibit slightly higher NadA expression. This suggests that NadR, 
although expressed to the same level, has a different repressive activity on the nadA 
gene transcription in each strain and this may depend on the number of repeats in the 
different phase variant promoters i.e. NadR does not efficiently repress the 8x promoter 
of 5/99 but very efficiently represses the 9x promoter of MC58.  
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Figure 12: NadR represses NadA expression. (A) EMSA assay performed with MC58 and Δ1843 cell 
extract on GPR probe showing the lack of binding activity in absence of NadR. (B) Western Blot analysis 
of the level of expression of NadA and NadR in wild type strains 5/99, BZ83, ISS838, 961-5945 and 
MC58 carrying nadA promoters with 8, 5, 6, 12, and 9 repeats respectively, and their NadR null mutant 
derivatives. Cells were recovered from overnight culture on plates and 5 µg of total protein were loaded 
on SDS-PAGE, blotted and stained with anti-NadA or anti-NadR polyclonal antiserum. 
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1.20 NadR represses to a different extent different phase variant 
promoters 
 
To further test the latter hypothesis and to rule out effects due to strain differences, we 
deleted the nadR gene in the isogenic MC58 strains carrying high (x8), medium (x6) 
and low (x9) promoter variants and measured the steady state levels of transcription 
from the promoters at log and stationary growth phase in the presence or absence of the 
NadR regulator. The results in Figure 13 confirm that in the mutant (Δ1843) all three 
promoters are derepressed and, interestingly, little or no variation in transcript levels 
between the phase variants is observed, suggesting that in the absence of NadR the 
mechanism of transcriptional control exerted by variable number of repeats is alleviated 
or negligible. It is worth noting, however, that the maximum level of transcription in 
exponentially growing cells is observed from the promoter variant with 8 repeats, in 
agreement with higher NadA expression in 5/99-Δ1843, suggesting that NadR is not the 
sole modulator of phase variable promoter activity and that there is another factor which 
may establish differential RNAP contacts to modulate transcription.  
Furthermore, we also measured the transcript level of the PΔ promoter, which lacks the 
TAAA tract and also no longer binds IHF, in the wild type and Δ1843 backgrounds and 
results indicate that NadR does not efficiently repress this mutant promoter (lanes 9 and 
10 versus 1 and 2) and implicates a major role for IHF in efficient NadR-mediated 
repression of the nadA promoter. 
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Figure 13: The NadR repressor contributes to phase variable expression. Transcription of phase variant 
promoters with 0, 9, 6, and 8 repeats, in the MC58 and NadR null mutant backgrounds. Total RNA was 
prepared from cultures of strains MC-PΔ, MC-P2(x9), MC-P2(x6), MC-P2(x8), Δ1843-PΔ, Δ1843-
P2(x9), Δ1843-P2(x6), and Δ1843-P2(x8),  grown to mid-log and stationary growth phase. Quantitative 
primer extension was performed as described in materials and methods. 
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1.21  4-hydroxyphenylacetic acid (4HPA) interacts with NadR and 
derepresses NadA expression 
The MarR family of proteins regulates a wide variety of biological processes including 
resistance to antibiotics and antimicrobial agents, virulence and environmental sensing 
of aromatic compounds (Wilkinson and Grove 2006) (Ellison and Miller 2006). They 
respond to small inducer molecules which attenuate the ability of MarR homodimers to 
bind their cognate DNA sequences (Wilkinson and Grove 2006), and are often the 
molecular substrates for the efflux pumps or metabolic pathways that are repressed by 
this family of regulators. We set about identifying a small molecule inducer, which may 
regulate NadR-mediated repression of NadA expression in meningococcus. We 
assessed broad-specificity inducers such as salicylic acid, which have been shown to be 
active against many members of this family, and also functionally relevant molecules 
such as long-chain fatty acids, which are the substrate for the regulated efflux pump of 
the gonococcal NadR homologue FarR (Lee, Rouquette-Loughlin et al. 2003) with no 
success. However, we noticed that immediately downstream of the nadR gene is an 
ORF which encodes a putative flavoprotein oxidoreductase with 42% amino acid 
identity to the small subunit of 4-hydroxyphenylacetic acid 3-hydroxylase. In addition, 
the closest BLAST neighbour of NadR in the MarR family of repressors is the HpaR 
protein (50% identity), which represses the 4-hydroxyphenylacetic acid (4HPA) 
catabolic pathway in E. coli. Moreover, it is responsive to the 4HPA substrate of the 
pathway, which binds to the repressor and induces expression of the catabolic genes 
(Galan, Kolb et al. 2003). We therefore, assessed whether the 4HPA molecule could act 
as putative inducer of NadA expression in vivo. Addition of 1 mM or 5 mM 4HPA 
(Figure 14A) to cultures of MC58 significantly induced NadA expression. No induction 
could be detected in cultures of the Δ1843 mutant, indicating that the 4HPA molecule 
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induced a NadR-mediated derepression of NadA expression. Then we further analyse 
transcript level of nadA after treatment of MC58 cultures with increasing concentration 
of 4HPA. As shown in figure 14 B nadA transcript increases upon addition of 200µM of 
the molecule and reaches the maximum at 1 mM after only 10 minutes of treatment 
(Figure 14 B lanes 3, 4), suggesting that the induction is directly at the level of promoter 
derepression. To confirm that the observed increases in NadA expression could 
represent a direct interaction of the inducer with NadR, the ability of the compound to 
dissociate purified recombinant NadR from the high affinity operator OpI was assessed 
by EMSA. The 4HPA compound was found to attenuate the binding activity of the 
NadR regulator to the GPR probe in vitro (Figure 14C). Furthermore, addition of 1 mM 
4HPA to crude cell extracts containing the native NadR meningococcal protein resulted 
in complete inhibition of retardation of the GPR probe in EMSA (data not shown), 
suggesting that the recombinant and native NadR proteins respond in vitro similarly to 
the compound. These data suggest that the 4HPA could be a ligand of the NadR 
repressor and interaction of the ligand with the protein attenuates the DNA-binding 
activity of the molecule for its specific operators and results in derepression or induction 
in vivo of the nadA promoter. 
 
 52 
 
 
Figure 14 (A) Induction of expression of NadA by addition of a small molecule ligand 4-hidroxy phenyl 
acetic acid (4HPA). Broth cultures of MC58 or Δ1843 were grown to OD600 of 0.24 without (lane 1) or 
with 1mM or 5mM (lane 2 and 3) 4HPA; or to OD600 of 0.24 and then incubated with 0, 1 or 5mM 4HPA 
(lanes 4-6) added for 1 h. Cells were harvested and 5 µg of total protein from each culture was subjected 
to SDS-PAGE and Western Blot analysis with anti-NadA or anti-NMB2091 antibodies as negative 
control. (B) Primer extension showing nadA transcript level from total RNA of MC58 strain grown at 
OD600 of 0.5 and treated for 10 minutes with 0, 0.04, 0.2, 1 and 5 mM of 4HPA (lanes 1-5 respectively). 
(C) EMSA assays demonstrating dissociation of NadR from OpI operator in the GPR probe in vitro 
following the addition of 4HPA (lanes 3-5) but not the broadly acting salicylic acid ligand (lanes 6-8). 
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 Discussion 
Host-pathogen interaction is a dynamic process that can lead to different outcomes such 
as the clearance of the pathogen, the establishment of a disease or a sort of equilibrium 
leading to commensalism. The factors that lead N. meningitidis to establish a productive 
infection, switching from commensal to pathogenic, thought to be dependent on both 
the host and the pathogen are still poorly understood. For these reasons, a better 
understanding of the causes and mechanism that mediate the expression of proteins 
involved in the interaction with host tissues is needed, both for predicting the 
effectiveness of a vaccine which contains these proteins, as well as for characterizing at 
the molecular level, novel strategies in the ever changing fight between pathogens and 
their host.   
In this scenario N. meningitidis has to arrange in concert the expression of a variety of 
different genes in order to adapt and survive in the different tissues during an infection 
of the human host. At the same time the bacteria must also escape the host immune 
response, which targets mostly the same structures used by the meningococcus to 
interact with the host. This issue is addressed by the high redundancy and variability in 
the expression of surface structure and by the ability to acquire genes from other 
bacteria species.  
The low GC content, with respect to the average of the genome, and the presence of a 
repeated sequence (TCAGAC) flanking the nadA gene, suggest it was acquired by 
horizontal transfer (Comanducci, Bambini et al. 2002). Another repeated tract present in 
the nadA locus (TAAA tetranucleotide repeated tract upstream of the promoter), has 
been found to be responsible for its phase variable expression (Martin, Makepeace et al. 
2005). 
Phase variation is the adaptive process by which bacteria undergo frequent and 
reversible phenotypic changes resulting from genetic alterations in specific loci of their 
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genomes and this process is crucial for the survival of pathogens and commensals in 
hostile and ever-changing host environments. N. meningitidis has an unprecedented 
potential for generating genetic diversity through slipped strand mispairing of simple 
sequence repeats, as its genome contains over 100 repeat associated genes (Saunders, 
Jeffries et al. 2000; Snyder, Butcher et al. 2001). The way in which genes are affected 
by variation in the number of repeats is largely thought to occur through biphasic on/off 
translational control due to frameshifting within the ORFs of coding regions. Recently 
the on/off switching of methyltransferase genes has been shown to co-ordinate 
expression of a phase-variable regulon of genes or "phasevarions" via differential 
methylation of the genome (Srikhanta, Maguire et al. 2005) (Srikhanta, Dowideit et al. 
2009). The role of simple sequence repeats in intergenic regions in modulating phase 
variable expression, although frequently found, are less easy to predict. However, 
differential spacing due to repeated tracts between the core promoter elements 
modulating multi-phasic expression by affecting RNAP sigma factor binding has been 
frequently reported (Sarkari, Pandit et al. 1994) (Carson, Stone et al. 2000) (van Ham, 
van Alphen et al. 1993) (van der Ende, Hopman et al. 2000),  as well as some 
documented examples where repeats in 5’UTR (Dawid, Barenkamp et al. 1999) 
(Lafontaine, Wagner et al. 2001) and distally upstream (Martin, van de Ven et al. 2003) 
(Dawid, Barenkamp et al. 1999) (Puopolo and Madoff 2003) (Liu, Panangala et al. 
2002) of promoters have been shown to affect expression through unknown 
mechanisms.  
In this study, we dissect the cis- and trans-acting elements as well as environmental 
factors that control transcriptional regulation of the nadA promoter in order to elucidate 
the mechanism by which sequence repeats distally upstream of the PnadA promoter 
controls its activity. We describe a complex promoter architecture in which spontaneous 
changes in the number of simple sequence repeats in a tract between the most distal 
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regulatory regions and the core promoter can alter the promoter activity and lead to 
phase variable expression. We have shown that the NadR repressor is the major 
contributor to the phase variable expression levels of the promoter as it binds to two 
high affinity operators flanking the repeats. One operator overlaps the -10 region of the 
promoter and the transcriptional start site, and therefore, binding of NadR is consistent 
with its function as a repressor through sterically hindering RNAP access to the 
promoter. The other high affinity operator is on the distal upstream side of the phase 
variable repeat in a cis-acting region that we call the GPR, which is functionally active 
in repressing the promoter despite its distal location (Figure 8). We have identified a 
single IHF binding site that is located between these two high affinity operators and we 
show that IHF binding to this promoter is necessary for efficient NadR-mediated 
repression of PnadA. The IHF binding site comprises some sequence upstream of the 
TAAA as well as part of the TAAA tract itself. If the TAAA tract is removed, the 
protein no longer binds the mutant promoter (Figure 7). However, we found that IHF 
binding is unaffected by the number of TAAA repeats, but rather the number of repeats 
may change the spacing of the DNA on the upstream and downstream flanking regions 
of the tract and, therefore, may influence the localisation, and possibly the orientation of 
proteins that bind to the operators. The ability of IHF to bend DNA may facilitate the 
looping of the DNA of the nadA promoter and bring the GPR element proximal to the 
core promoter elements. A looping mechanism (Figure 15) would explain the function 
of such a distal operator in repression of transcription, possibly through interactions of 
dimers present on spatially proximal operators which lock the promoter to RNAP 
similar to the mechanism described for the lac operon (Oehler, Eismann et al. 1990) 
(Lewis, Chang et al. 1996). 
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1.22 Three-dimensional MODEL 
 
 
Figure 15: Three-dimensional structure of nadA promoter region. The spatial conformation of the DNA 
filament is predicted on the basis of its sequence composition (Predictor and Swiss-pdbViewer). Forward 
strands of two nadA phase variants promoters (x9 and x8 TAAA repeats) are shown, superimposed from 
their 3’ ends. The -35 and -10 examers are indicated and two nucleotides corresponding to the centre of 
the binding sites for IHF (green) and NMB1843 (purple), identified by footprinting, are shown in Space-
Fill mode and depicted with either white or red arrows (for phase variant promoters with 9 and 8 repeats 
respectively). 
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 However, in the completely derepressed form there are still significant, albeit marginal 
differences in the promoter strength of variants with different numbers of repeats. The 
alpha-subunit of RNAP binds to the distal GPR regulatory region and also immediately 
upstream of the core promoter overlapping the TAAA tract which may function as UP-
like elements. We propose a model in which differential distancing between the nadR 
operators and the contact points of RNAP result in optimal or suboptimal configuration 
of the protein complexes and, therefore, result in more or less efficient repression 
mediated by NadR and/or more or less cis-enhancement of RNAP activity on the basal 
promoter strength (Figure 16). 
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1.23 Regulation MODEL 
 
Figure 16: Model of regulation of NadA promoter: Two promoter variants with 9 and 8 repeats 
representing low activity and high activity promoter phase variants, respectively, highlighting the ability 
of NadR to efficiently or less efficiently repress the promoters (top panels) and NadR-independent effects 
on the derepressed promoter basal levels possibly due to differential contacts with the α-subunit of RNAP 
(bottom panels) due to different spatial organization of the NadR and RNAP contact points resulting from 
the different number of repeats. 
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 Interestingly, in Pu promoter of P. putida, two distinct UP elements, located close to 
the core promoter (-79) and distally upstream (-104), interact with RNAP α-subunits 
enhancing gene expression (Macchi, Montesissa et al. 2003). This interaction is 
modulated by IHF that allow the interchangeable positioning of the two α-subunits over 
the two UP-elements (Macchi, Montesissa et al. 2003) (Bertoni, Fujita et al. 1998). This 
scenario resembles in part what we observe with α-subunit interaction over nadA 
promoter.  
The gonococcal homologue of NadR is FarR, which has been characterised in 
gonococcus as a repressor of the FarAB fatty acid resistance efflux pump (Lee, 
Rouquette-Loughlin et al. 2003). FarR binds two distal operators on the farAB promoter 
(located similarly to OpI and OpII in the nadA promoter) and represses transcription in 
an IHF dependent way. It would appear from deletion analysis of the nadA promoter 
that all regulatory elements necessary for control of nadA expression were horizontally 
transferred together with the nadA gene, as the direct repeat delineating the border of 
the transferred DNA is at -193. The intriguing question is then how the nadA locus, 
which is present in only a fraction of strains, through a horizontal transfer event, 
adopted such a complex regulatory mechanism pre-existing in Neisseria. The nadR 
gene is well conserved in other Neisseria spp such as N .mucosa, N. cinerea, N. 
lactamica, N. subflavia and N.  flavescens and, therefore, must respond to signals in the 
ecological niches of all these species.  
The NadR protein is a member of the MarR ligand-responsive transcriptional regulators 
and the majority of MarR family members are regulated by the non-covalent binding of 
low molecular weight ligands. These signalling molecules regulate the activity of the 
regulators. In this study, we have identified a putative ligand, 4-hydroxyphenylacetic 
acid, which is able to relieve the DNA binding activity of NadR, thus derepressing or 
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inducing NadA expression. This molecule is a catabolite of aromatic amino acids and it 
is secreted in human saliva (Takahama, Hirota et al. 2003) (and also urine), suggesting 
that the inducer is present in the oropharynx and NadA may be induced in the mucosal 
niche, which is bathed in saliva.  
The 4HPA molecule is a catabolite of the aromatic amino acids, tyrosine and 
phenylalanine. Two groups of bacteria, the soil inhabitants such as P. putida and the 
enteric bacteria such as E. coli contain pathways for the breakdown of these amino acids 
to succinate and pyruvate (Diaz, Ferrandez et al. 2001). However, such a pathway is not 
present in the meningococcal genome (Tettelin, Saunders et al. 2000). Nevertheless, 
nadR is present in a operon-like organization with 2 downstream genes one of which 
shows significant homology to the HpaC small subunit of a hydroxylase involved in the 
conversion of 4HPA to a less toxic form (3,4-dihydroxyphenylacetic acid). It is unclear 
whether this operon may be involved in the utilisation of 4HPA inducer in some way in 
meningococcus, or whether it is the remnant of a partial catabolic pathway that was 
acquired horizontally and the 4HPA molecule simply acts as a signal inducing the 
expression of the adhesin, which is necessary for colonization and invasion of the 
mucosa. 
Phase variation functions as an adaptive strategy generating spontaneous diverse sub-
populations of the bacterium which may be beneficial in adapting to different 
microenvironments within the human host during the course of a natural infection. 
However, in the case of nadA gene regulation, this type of mechanism is bi-functional, 
in that the major mediation of phase variable expression levels of NadA is through 
repression by NadR protein in the absence of the correct inducer signal. Subpopulations 
expressing low levels of NadA through promoter phase variations still have the 
potential to respond to the correct niche signal, such as 4HPA, and express high levels 
under certain environmental or niche-specific conditions. Such variation will have an 
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impact on the interaction with the host tissues, as well as escaping immune responses. 
Simple sequence repeats have been identified in distal promoter regions of known or 
potential virulence factors in other pathogens including Helicobacter pylori (Saunders, 
Peden et al. 1998), H. Influenza (Dawid, Barenkamp et al. 1999) (Parkhill, Achtman et 
al. 2000), Moraxella catarrhalis (Linton, Karlyshev et al. 2001), Group B Streptococcus 
(Puopolo and Madoff 2003) and pathogenic Mycoplasma (Liu, Panangala et al. 2002) 
some of which have been shown to control phase variable expression through unknown 
mechanisms. This suggests that complex regulatory mechanisms such as what we have 
elucidated for NadA involving stochastic variations and environmentally-responsive 
transcription factors may be widely used by pathogens. Elucidating these mechanisms is 
important for our understanding of the intimate and complex relationship between the 
host and disease-causing organisms.  
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Materials and Methods 
 
1.24 Bacterial strains and culture conditions 
The N. meningitidis strains used in this study are all listed in Table II. N. meningitidis 
strains were routinely cultured in GC-based (Difco) agar medium supplemented with 
Kellogg’s supplement I (Kellogg et al., 1963) at 37°C in a 5% CO2-95% air atmosphere 
at 95% humidity. Strains were stocked in 10% skim milk and stored at -80°C. For liquid 
cultures, N. meningitidis strains were grown overnight on solid medium, re-suspended 
in GC broth to an optical density at 600 nm (OD600) of 1, and inoculated with a 1:20 
dilution into GC broth supplemented with Kellogg’s supplement I, 12.5 µM Fe(NO3)3 
or Mueller Hinton (MH) (Sigma, St. Louis, MO) containing 0,25% glucose and, when 
required, erythromycin and/or chloramphenicol added to achieve final concentrations of  
5 µg ml-1. For transformation by naturally competent N. meningitidis, four to five single 
colonies of a freshly grown overnight culture were re-suspended in 20 µl of PBS, 
spotted onto GC plates, and 5–10 µg of linearized plasmid DNA was added, allowed to 
dry and incubated for 6–8 h at 37°C. Transformants were then selected on plates 
containing erythromycin (5 µg ml-1) and/or chloramphenicol (5 µg ml-1), and single 
colonies were re-streaked on selective media for further analysis. Transformants were 
re-suspended in 50 µl of distilled water, placed in a boiling water bath for 5 min and 
centrifuged in a bench top centrifuge for 5 min at 8000 g. One microlitre of the sample 
was used as template for PCR analysis for correct insertion by a double homologous 
recombination event, and nadA promoter regions were amplified and sequenced to 
verify that no phase variation had occurred during manipulations. E. coli DH5-α 
(Hanahan 1983) and BL21(DE3) (Studier and Moffatt 1986) cultures were grown in 
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Luria–Bertani medium, and when required, ampicillin chloramphenicol and/or IPTG 
were added to achieve final concentrations of 100, 20 µg ml-1 and 1mM respectively. 
 
1.25 DNA techniques. 
DNA manipulations were carried out routinely as described by Sambrook, Fritsch et al. 
1989. Small- and large-scale plasmid DNA preparations were carried out with a 
QIAprep Spin Mini kit and Plasmid Midi kit (QIAGEN) according to the 
manufacturer’s instructions. DNA fragments or PCR-amplified products were purified 
from agarose gels with QiaEX DNA purification kit (QIAGEN). PCR was performed in 
a Perkin-Elmer 2400 thermal cycler with Platinum Taq polymerase (Invitrogen). One 
microlitre of each reaction mixture contained 10–50 ng of chromosomal DNA or 1 µl 
bacterial sample (see above), 100 pmols of the required primers and 200 µM 
concentration of each deoxynucleotide in a volume of 100 µl of 1 x PCR buffer 
containing MgCl2 (Invitrogen). After the initial denaturing step at 95°C for 5 min, 30 
cycles of denaturing at 95°C, annealing at the appropriate temperatures for the specific 
primers and elongation at 72°C were carried out. DNA fragments were routinely 
sequenced according to the dideoxy-chain termination method (Sanger, Air et al. 1977) 
by using [α-32P]-dATP (NEN, Perkin Elmer) and a T7 sequencing kit (Pharmacia). 
 
1.26 Construction of nadA promoter fusions  
In order to analyze cis-elements involved in regulation of nadA expression a series of 
plasmids carrying nadA promoters fused to the gfp gene were constructed, which could 
be assayed in E. coli and also used for allelic exchange in N. meningitidis strains at a 
chromosomal location between two converging open reading frames (ORFs), 
NMB1074 and NMB1075. A plasmid consisting of a promoterless gfp gene and the 
ermAM erythromycin-resistance genes flanked by upstream and downstream regions for 
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allelic replacement was generated (pGFP, (Ieva, Roncarati et al. 2008)). A series of 5’ 
deletion variants of nadA promoter were generated by PCR amplification from the 
genome of MC58 using primers Nad-N1, Nad-N2, Nad-N3, Nad-N4 and Nad-N5 as 
forwards and Nad-Sp as reverse, generating P1, P2, P3, P4 and P5 promoter deletion 
fragments respectively, spanning from -273, -170, -108, -49, and -9, respectively, to +79 
with respect to the transcriptional start site. The 5 promoter fragments were cloned 
using NsiI and SphI sites, introduced by primers design into the pGFP plasmid and used 
for transformation of MC58 generating the MC-P1, MC-P2, MC-P3, MC-P4, amd MC-
P5 strains respectively. (Table II and Figure 8). Phase variant nadA promoters with 
different repeat numbers, from 4 to 13, were PCR amplified with the Nad-N2/Nad-Sp 
primer pair using as a template genomic DNA from different clinical isolates with the 
appropriate number of repeats as major clone kindly donated by Maurizio Comanducci 
and Stefania Bambini. All promoters fragments generated, (spanning from -170 to +79 
with respect to the +1 in MC58) were then cloned as NsiI- SphI fragments into the 
pGFP plasmid and used for transformation of MC58 generating the MC-P2x4, MC-
P2x5, MC-P2x6, MC-P2x7, MC-P2x8, MC-P2x9, MC-P2x10, MC-P2x11, MC-P2x12, 
MC-P2x13 strains respectively. (Table II and Figure 5). The PΔ  nadA promoter variant, 
lacking the TAAA tetranucleotide repeat, was generated by PCR amplificaion of 
regions upstream and downstream of the TAAA repeated tract, using primer pairs Nad-
N2/n85-50R and n85-50F/Nad-Sp. Then, in a second round of PCR, the respective 
upstream and downstream fragments, which contain regions of overlap due to the 
primer design, were used in a self-priming PCR amplification for 5 cycles, and then the 
corresponding united fragments were amplified using the external primers Nad-N2/Nad-
Sp, and cloned into pGFP. The pGFP-PΔ plasmid was used for the transformation of 
MC58 generating MC-PΔ, containing a nadA promoter fusion in which the TAAA 
repeated tract was substituted with an EcoRI site (Table II and Figure 8).  
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1.27 Construction of knockouts 
In order to knockout the NMB1843 gene in the Neisseria background, the 
pΔ1843ko::Cm plasmids was constructed. Upstream and downstream flanking regions 
of the NMB1843 gene were amplified by PCR with the 1843-1/1843-2b and 1843-
3b/1843-4 primers respectively. Then in a second round of PCR the respective upstream 
and downstream fragments, which contain regions of overlap due to the design of the 
primers, were used in a self-priming PCR amplification for 5 cycles, and then the 
corresponding united fragment was amplified using the external 1843-1/1843-4 primers. 
This product was cloned into the pGEM-T (Promega) vector and a chloramphenicol 
cassette from pDT2548 (Wang and Taylor 1990) was inserted into the unique BamHI 
site, between the flanking regions, generating pΔ1843ko::Cm. The plasmid was then 
linearised and used for transformation of the meningococcal strains to make the 
respective NMB1843 knockout mutants (Table II). The correct double homologous 
recombination event resulting on the knockout of the genes was verified by PCR.   
 
1.28 Expression and purification of the E.coli RNA polymerase α-
subunit and N. meningitidis NMB1843 protein. 
The NMB1843 gene was amplified from the MC58 genome with the 1843-F/1843-R 
primer pair and cloned as a 448 bp NdeI-BamHI fragment into the pET15b expression 
plasmid (Invitrogen) generating pET15-1843 which was subsequently transformed into 
the E. coli strain BL21(DE3) for protein expression. For alpha subunit expression, 
plasmid pHTT7f1-NHα  (Tang, Severinov et al. 1995) was transformed into E. coli 
strain BL21(DE3). From an overnight culture of the BL21(DE3)(pET15-1843) and 
BL21(DE3)(pHTT7f1-NHa)  strains, 200 ml of Luria-Bertani medium was inoculated 
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and grown to an OD600 of 0.5, and expression of the recombinant NMB1843 or E.coli 
RNApol α-subunit proteins containing an N-terminal histidine tag was induced by the 
addition of 1 mM IPTG (isopropyl-D-thiogalactopyranoside) and further incubation for 
3 h. The proteins were purified from the harvested cells by Ni-nitrilotriacetic acid 
(QIAGEN) affinity chromatography under nondenaturing conditions according to the 
manufacturer’s instructions. The purified protein preparation was then diluted to 1 
mg/ml and dialyzed overnight in 1 x Binding Buffer (20 mM Tris-HCl pH 8, 50 mM 
KCL, 10 mM MgCl2, 01% NP40) containing 10% glycerol and then again overnight in 
1x Binding buffer containing  50% glycerol. The purity of the proteins was estimated to 
be greater than 98% by sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE). The concentration of the proteins in this preparation was determined by 
using the Bradford colorimetric assay (Bio-Rad), and the protein was aliquoted and 
stored at -80°C. To generate anti-NMB1843 antibodies, 6-week-old female CD1 mice 
(Charles River Laboratories) were immunized with 20 µg of NadR protein given 
intraperitoneally, together with complete Freund's adjuvant in three doses (day 1, 21 and 
35). Bleed-out samples were taken on day 49 and used for Western blot analysis. 
 
1.29 Western blot analysis  
N. meningitidis colonies from overnight plate cultures were either resuspended in PBS 
until OD600 of 1, or grown to logarithmic phase (OD of 0.5, ca. 2 hours incubation) and 
stationary phase (OD ≥ 0.9 ca. 5 hours incubation) from a starter inoculum of OD 0.05. 
Samples of 1-2 ml were harvested and normalised in 1xSDS-PAGE loading buffer (50 
mM Tris Cl pH 6.8, 2.5 % SDS, 0.1 % Bromophenol Blue, 10% glycerol, 5% B-
mercapto-Ethanol, 50 mM DTT) to a relative OD of 5. For Western blot analysis, 10 µg 
of each total protein sample in 1 x SDS-PAGE loading buffer was separated by SDS-
PAGE, and transferred onto nitrocellulose membrane using an iBlot Dry Blotting 
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System (Invitrogen). Membranes were blocked overnight at 4C° by agitation in 
blocking solution (10% skimmed milk, 0.05% Tween-20, in PBS) and incubated for 90 
min at 37°C with anti-NadA or anti-NMB1843 polyclonal sera) in blocking solution. 
After washing, the membranes were incubated in a 1:2000 dilution of peroxidase-
conjugated anti-rabbit immunoglobulin (Biorad) or anti-mouse immunoglobulin (Dako) 
respectively, in blocking solution for 1 hour and the resulting signal was detected using 
the Supersignal West Pico chemiluminescent substrate (Pierce).  
 
1.30 Co-over expression of alpha subunit in E. coli 
In order to allow co-expression in E. coli of nadA promoter fusions with pLAW2 
(overexpressing RNAP α-subunit) and pLAW2Δ256 (overexpressing the N-terminus of 
α-subunit), pXG-1 plasmid (Urban and Vogel 2007), harbouring pSC101 origin of 
replication and a cloramphenicol resistance cassette, was used simply substituting the 
181 bp AatII/NheI fragment containing the PLtetO-1 promoter with different nadA 
promoter phase variants amplified with nad-Aa2/nadNh primer pairs (Table I), 
generating nadA-gfp translational fusions. 
To evaluate the role of RNAP alpha-subunit in regulation of transcription from the nadA 
promoter, we co-transform pLAW2 or pLAW2Δ256 with pXG harbouring nadA-gfp 
fusions in E. coli. After liquid growth to an OD600 of 0.5 in presence of 1 mM IPTG for 
induction of α expression, GFP fluorescence was measured in 48 well plates using 
TECAN Infinite 200 with excitation wavelength of 460 nm and an emission of 510 nm. 
Experiments were performed in triplicate. 
 
 69 
1.31 Crude extract preparation, DNA affinity purification of GPR-
binding protein and Electrophoretic mobility shift assay 
(EMSA) 
N. meningitidis strains were growth until OD600 of  0.5 as described above, then 100 ml 
were harvested and resuspended in 10 ml of PBS, sonicated at maximum power (20 
impulse of 0,8 second each) for 5 times at +4 °C and the cell debris was removed by 
centrifugation at 8,000xg for 15 min. The soluble fraction was then filtered using a 0.2 
µm membrane and stored at 4 °C. Proteins concentration in the sample was determined 
using the Bradford colorimetric assay. 
For the characterization of the binding activity in the cell extract, it was precipitated, 
where indicated, with ammonium sulphate salts by adding, from a saturated solution, 
the amount to reach 20, 40, 60 and 70% concentration. Cell extracts were also incubated 
at different temperatures (40, 60 and 100°C) for 30 minutes or with 5 µg of Trypsin 
(Promega) or Proteinase K (Gibco BRL) for 30 minutes or 2 hours as indicated. 
For purification of GPR-binding protein from MC58 crude extract a probe spanning 
from -170 to -116 with respect to the MC58 nadA promoter was amplified using a 5’ 
biotinylated forward primer Bio-nadN2 (Invitrogen custom primers) and gpr-R reverse 
primer. 25 pmoles of the fragment were incubated with 1.3 ml of MC58 crude extract 
(0.6µg/µl) in presence of 100µg of salmon sperm DNA and 500µg bovine serum 
albumin (BSA) to block non specific interactions for 20 minutes at room temperature 
with gentle rotation. The mixture was then added to 2,5 mg of Dynabeads M-280 
streptavidin (Invitrogen), previously washed 4 times with 250 µl PBS, and incubated for 
20 minutes at room temperature with gentle rotation. The tube was then placed on a 
magnet for 2 minutes for magnetic separation of the beads and after 3 washes with PBS, 
proteins bound to biotinylated GPR were eluted in 400µl of 1M NaCl. The sample was 
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then dialyzed over night against H2O at 4 C°. All fractions were then analysed for 
binding activity using EMSA assay, and eluted fraction was further analyzed using 
MALDI TOF. 
For gel shift experiments, a probe corresponding to the GPR element and spanning from 
-170 to -116 with respect to the MC58 nadA promoter was amplified using nad-N2/gpr-
R, a probe corresponding to the P5 promoter fragment spanning -9 to +81 was amplified 
with NadN5/Nad-Sp, a probe corresponding to P2 promoter fragment spanning -170 to 
+81 was amplified with nad-N2/ Nad-Sp, a probe corresponding to 6 TAAA repeats 
using primers IHF-Lex and IHF-Rex2 annealed and a probe corresponding to an 
unrelated intergenic region Pcon (157 bp between NMB2073 and NMB2074), was 
amplified using SR-F and SR-R. Two pmoles of each fragment were then radioactively 
labeled at their 5’ ends with 30 µCi of (γ-32P)-ATP (6000 Ci/mmol; NEN) using 10 U of 
T4 polynucleotide kinase (New England Biolabs). The unincorporated radioactive 
nucleotides were removed using the TE-10 chromaspin columns (Clontech). For each 
binding reaction, 40 fmoles of labeled probes was incubated with increasing amounts of 
crude extract or recombinant NMB1843 in 25 µl final volume of Gelshift Binding 
Buffer (25 mM Tris-HCl pH 7.5, 1mM MgCl2, 10% glycerol) with 2µg salmon sperm 
DNA as non-specific competitor, for 15 min at room temperature, and run on 6% native 
polyacrilamide gels buffered with 0.5x TBE at 100 Volts for 80 min at 4 °C. Gels were 
dried and exposed to autoradiographic films at –80°C and radioactivity was quantified 
using a phosphorimager and the Image Quant software (Molecular Dynamics). 
 
1.32 RNA preparation and Primer extension 
N. meningitidis or E. coli strains were grown in liquid culture to logarithmic or stationary 
phase and then 20 ml of cultures were added to an equal volume of equivalent frozen 
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medium to bring the temperature immediately to 4 °C and then centrifuged at 3,000 rpm 
in a benchtop centrifuge at 4º C. RNA was extracted from the pelleted cells as 
previously described (Spohn, Beier et al. 1997). Primer extension was performed as 
previously reported (Delany, Ieva et al. 2003). To ensure correct mapping of the 
promoter sequencing reaction was carried out with a T7 sequencing kit (USB 
Corporation) using the same primer as in the primer extension reactions and the plasmid 
consisting of the relevant cloned promoter. Quantification of the signals from the primer 
elongated product was performed using Phosphoimager and ImageQuant software 
(Molecular dynamics). For quantitative experiments, experiments were performed from 
at least 2 independent biological replicates and figures show results from one 
representative experiment. Internal negative controls were performed on each RNA set 
quantifying the specific transcript of a gene whose expression is not altered, usually adk 
or nmb1870. 
 
1.33 DNase I footprinting (NMB1843, Neisseria gonorrhoeae IHF, 
Escherichia coli RNApol and Alpha-sub) 
The nadA promoter region was amplified from genomic DNA from different clinical 
isolates with the appropriate number of repeats as major clone and from pGFP-PΔ 
plasmid for 0 repeat, using primers nad-N1 and nad-B1 and cloned as 320, 342, 346 and 
354  bp (for 0, 6, 7, 9 repeats respectively) NsiI-BamHI fragments into pGemT 
(Promega). A radioactive probe for DNA footprinting of nadA promoters were prepared 
as follows: approximately 2 pmol of the different plasmids were linearized with BamHI, 
subjected to dephosphorylation using CIP (New England Biolabs), and then 5’ end 
labelled using 5 pmol of [γ-32P]-ATP with T4 polynucleotide Kinase (New England 
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Biolabs). The plasmid was then digested with NsiI, and nadA promoter fragments, 
labelled at one extremity, were purified by preparative polyacrylamide gel 
electrophoresis (PAGE). Briefly, the probe was extracted from a 6% polyacrylamide gel 
and eluted in 3 ml of elution buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA, 300 mM 
Na acetate [pH 5.2], 0.2% sodium dodecyl sulfate [SDS]) at 37°C overnight. The eluted 
probe was then extracted once with an equal volume of phenol-chloroform (1:1) and 
ethanol precipitated. Protein-DNA complexes were formed in 50 µl of footprinting 
buffer (20 mM Tris-HCl, pH 7.9, 50 mM KCl, 10 mM MgCl2, 0.01% NP-40, 10% 
glycerol) containing approximately 20 fmol (10 000 c.p.m) of the labelled probe and 
200 ng of sonicated salmon sperm DNA as the non-specific competitor and recombinant 
NMB1843 protein, Neisseria gonorreae purified IHF (kindly donated by Hill SA, 
Belland RJ et al. 1997), E. coli RNA polymerase holoenzyme (USB) or alpha subunit 
(Tang, Murakami et al. 1996) in final concentrations as indicated, for 15 min at room 
temperature. Following incubation for 1 min at room temperature with 0.03 U of DNase 
I (Roche) and 5 mM CaCl2, the reaction was stopped by addition of 140 µl of stop 
buffer (192 mM Na acetate, 32 mM Na2EDTA, 0.14% SDS, 64 mg ml-1 of sonicated 
salmon sperm DNA). Samples were phenol-extracted, ethanol-precipitated, re-
suspended in denaturing sample buffer and fractionated on urea-6% polyacrylamide 
gels. As a molecular weight marker, a G+A sequence reaction (Maxam and Gilbert 
1977) was performed for each DNA probe and run in parallel to the corresponding 
footprinting reactions. 
 
1.34 MALDI TOF mass spectrometry 
Proteins eluted from Dynabeads M-280 streptavidin column and dialyzed against H2O 
were dried with a Speed Vac. (Labconco) and solubilized with 20 µl of 5 mM 
ammonium bicarbonate containing 0.1 % (wt/vol) of RapiGest™ SF surfactant 
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(Waters), incubated 5 min at 95°C and digested with 2 µg of trypsin (Sequencing grade 
Promega). The reaction was allowed to proceed for 15 hours at 37°C. An aliquot of the 
reaction was diluted 10 times with 0,1% (vol/vol) of trifluoroacetic acid, and 0.7 µl was 
directly spotted on a matrix PAC target (Prespotted AnchorChip 96, set for Proteomics, 
Bruker Daltonics). Air-dried spot was washed with 0.6 µl of a solution of 70% (vol/vol) 
ethanol, 0.1% (vol/vol) TFA. Peptide mass fingerprint spectra were recorded with a 
MALDI-TOF/TOF mass spectrometer UltraFlex (Bruker Daltonics). Ions generated by 
laser desorption at 337 nm (N2 laser) were recorded at an acceleration of 25 kV in the 
reflector mode. In general, about 200 single spectra were accumulated for improving the 
signal/noise ratio and analyzed by FlexAnalysis (version 2.4, Bruker Daltonics). 
External calibration was performed using standard peptides pre-spotted on the target. 
The data of MS were further analyzed through an in-house licensed MASCOT, version 
2.2.1 (Matrixscience Ltd), running on a local server containing the protein sequence 
data downloaded from NCBI. The following parameters were used for database 
searches: monoisotopic mass accuracy, 75 pm, missed cleavages, 1, oxidation of 
methionine as variable modifications. 
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Table 1. Oligonucleotides used in this study 
Name Sequence Site 
Nad-N1 attcagatgcatGACGTCGACGTCCTCGATTACGAAGGC NsiI 
Nad-N2 attcagatgcatTAAGACACGACACCGGCAGAATTG NsiI 
Nad-N3 attcagatgcatCCGAACTACCTAACTGCAAG NsiI 
Nad-N4 attcagatgcatTTGCGACAATGTATTGTATATATG NsiI 
Nad-N5 attcagatgcatCTTTAATATGTAAACAAACTTGGTGG NsiI 
Nad-Sp attcagcatgctacGCTCATTACCTTTGTGAGTGG SphI 
Nad-B1 attcaggatcctacGCTCATTACCTTTGTGAGTGG BamHI 
n-85/50F CTACCTAACTGCAAGAATTcTTGCGACAATGTATTG EcoRI 
n-85/50R CAATACATTGTCGCAAgAATTCTTGCAGTTAGGTAG EcoRI 
Bio-nad-N2 attcagatgcatTAAGACACGACACCGGCAGAATTG NsiI 
nad-Aa2 attcaggacgtcTAAGACACGACACCGGCAGAATTG AatII 
nad-Nh attcagctagcCATGCTCATTACCTTTGTGAGTGG NheI 
1843-1 TACGTTCCGGCAGTTCGGCGG  
1843-2b cgcatcctcgggatccGGGTAGGCATTGTTTAAGTCTCC BamHI 
1843-3b caaatgcctacccggatccCGAGGATGCGTTGAACTCGTAATAC
GCCG 
BamHI 
1843-4 ACCGCTCTTCGGGCGACAGGCCGG  
1843-F attcacatATGCCTACCCAATCAAAACATGCG NdeI 
1843-R attcaggatcCGGCGTATTACGAGTTCAACGCATCCTCG BamHI 
IHF-Lex ctagaACTGCAAGAATTAAATAAATAAATAAATAAATA
AATTGCGAC 
XbaI 
IHF-Rex2 ctagaGTCGCAATTTATTTATTTATTTATTTATTTAATTC
TTGCAGT 
XbaI 
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Gpe-3 GAATTGGGACAACTCCAGTG  
1870-pe  gaatcagggcagtggtcagag  
Adk-PE CGCGCCTAAAAGTAATGC  
gpr-R  gattagcatgcCGGCATTAATATCTGTTAATATGTGC SphI 
SR-F  TCGGAAGCCGTCCGTTCCGAACC  
SR-R attatggatccATAAACGCCAAACCCACCGCGAAGGTGG BamHI 
a Capital letters indicate N. meningitidis derived sequences, small letters indicate 
sequences added for cloning purposes, and underlined letters indicate restriction enzyme 
recognition sites. 
 
 
Table 2. Strains and Plasmids used in this study. 
Name Relevant characteristics Reference or 
source 
Neisseria meningitidis  
MC58 Clinical isolate, sequenced strain containing 9 
TAAA tetranucleotide repeats in the nadA 
promoter  
(Tettelin, 
Saunders et al. 
2000)  
5/99 Clinical isolate containing 8 TAAA tetranucleotide 
repeats in the nadA promoter 
Norwegian 
clinical isolate 
BZ83 Clinical isolate containing 5 TAAA tetranucleotide 
repeats in the nadA promoter 
(Comanducci, 
Bambini et al. 
2002) 
ISS838 Clinical isolate containing 6 TAAA tetranucleotide 
repeats in the nadA promoter 
(Comanducci, 
Bambini et al. 
2002) 
961-5945 Clinical isolate containing 12 TAAA 
tetranucleotide repeats in the nadA promoter 
(Comanducci, 
Bambini et al. 
2002) 
MC-Δ1843 1843 null mutant in MC58 strain, CmR This study 
5/99-Δ1843 1843 null mutant in 5/99 strain, CmR This study 
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BZ83-Δ1843 1843 null mutant in BZ83 strain, CmR This study 
ISS-Δ1843 1843 null mutant in ISS838 strain, CmR This study 
961-Δ1843 1843 null mutant in 961-5945 strain, CmR This study 
MC-P(1-5) Series of 5 derivatives of MC58, containing single 
copy transcriptional fusion of 5’ deletions of the 
nadA promoter fused to the gfp gene, EryR 
This study 
MC-PΔ Derivative of MC58, containing single copy 
transcriptional fusion of a mutant variant of the 
nadA promoter, with the tetranucleotide repeats 
deleted, fused to the gfp gene, EryR 
This study 
MC-P2(x4-
x13)  
Series of 10 derivatives of MC58, containing single 
copy transcriptional fusion of the nadA P2 
promoter variants, containing from 4 to 13 
tetranucleotide repeats, fused to the gfp gene, EryR  
This study 
Δ1843-PΔ, -
P2(x6, x8, x9) 
4 Derivatives of MC-Δ1843, containing single 
copy transcriptional fusion of the nadA P2 
promoter with either  0, 6, 8 or 9 tetra nucleotide 
repeats, fused to the gfp gene, EryR 
This study 
MC-Fko Fur null mutant of MC58 (Delany, Ieva et 
al. 2003)  
Fko-P2(x9) Derivative of MC-Fko containing single copy 
transcriptional fusion of the nadA P2 promoter with 
9 repeats, fused to the gfp gene, EryR  
This study 
Plasmids  
pGEMT Cloning vector, AmpR Promega 
pΔ1843ko::Cm Construct for generating knockout of the 
NMB1843 gene, CmR 
This study 
pGFP Construct for insertion of nadA promoter variants 
and mutants fused to gfp in single copy between 
ORF nmb1074 and NMB1075 in the N. 
meningitidis chromosome, AmpR, EryR 
(Ieva, Roncarati 
et al. 2008) 
pGX-1 Derivative pSC101 containing the gfp gene, CmR (Urban and Vogel 
2007) 
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pGX-nad Derivative of pGX-1 (Urban et al. 2007) with the 
nadA promoters cloned as a AatII/NheI fragment 
upstream of the gfp gene, CmR 
This study 
plaw2 Expression vector for over-expression of alpha 
subunit of RNA polymerase under an IPTG-
inducible promoter, AmpR 
 (Zou, Fujita et al. 
1992) 
plaw2Δ(1-235) Expression vector for over-expression of N-
terminus of the alpha subunit of RNA polymerase 
from amino acids 1-235, under an IPTG-inducible 
promoter, AmpR 
 (Zou, Fujita et al. 
1992) 
pHTT7f1-NHα Vector for expression of N-terminal Histagged 
alpha subunit of RNA polymerase protein under an 
IPTG-inducible promoter, AmpR 
(Tang, Severinov 
et al. 1995) 
pET15b Expression vector for N-terminal Histagged 
proteins, AmpR 
Invitrogen 
pET15b-1843 pET15b derivative for expression of recombinant 
1843 protein, AmpR 
This study 
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